US20230190368A1 - Apparatus and methods for renal denervation ablation - Google Patents
Apparatus and methods for renal denervation ablation Download PDFInfo
- Publication number
- US20230190368A1 US20230190368A1 US18/170,348 US202318170348A US2023190368A1 US 20230190368 A1 US20230190368 A1 US 20230190368A1 US 202318170348 A US202318170348 A US 202318170348A US 2023190368 A1 US2023190368 A1 US 2023190368A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- electrode
- opening
- electrodes
- lumen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002679 ablation Methods 0.000 title claims abstract description 36
- 230000008660 renal denervation Effects 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims description 22
- 210000004369 blood Anatomy 0.000 claims abstract description 44
- 239000008280 blood Substances 0.000 claims abstract description 44
- 238000004520 electroporation Methods 0.000 claims description 35
- 230000002427 irreversible effect Effects 0.000 claims description 26
- 239000000463 material Substances 0.000 claims description 17
- 210000002254 renal artery Anatomy 0.000 claims description 17
- 230000017531 blood circulation Effects 0.000 claims description 12
- 238000009413 insulation Methods 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 9
- 229920002635 polyurethane Polymers 0.000 claims description 9
- 239000004814 polyurethane Substances 0.000 claims description 9
- 239000004809 Teflon Substances 0.000 claims description 7
- 229920006362 Teflon® Polymers 0.000 claims description 7
- 230000015556 catabolic process Effects 0.000 claims description 7
- 238000004891 communication Methods 0.000 claims description 7
- -1 polyethylene Polymers 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- 230000037361 pathway Effects 0.000 claims description 4
- 239000004677 Nylon Substances 0.000 claims description 3
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 229920001778 nylon Polymers 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 239000004696 Poly ether ether ketone Substances 0.000 claims description 2
- 229920002530 polyetherether ketone Polymers 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 claims 1
- 239000000615 nonconductor Substances 0.000 abstract description 4
- 230000005684 electric field Effects 0.000 description 53
- 210000001519 tissue Anatomy 0.000 description 17
- 230000002792 vascular Effects 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 11
- 210000001640 nerve ending Anatomy 0.000 description 10
- 239000011800 void material Substances 0.000 description 10
- 210000004204 blood vessel Anatomy 0.000 description 9
- 239000012212 insulator Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 230000002051 biphasic effect Effects 0.000 description 7
- 239000004020 conductor Substances 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 238000005094 computer simulation Methods 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 238000004088 simulation Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000004026 adhesive bonding Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000005530 etching Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000000750 progressive effect Effects 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000002716 delivery method Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical class [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229910000566 Platinum-iridium alloy Inorganic materials 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 230000003685 thermal hair damage Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00273—Anchoring means for temporary attachment of a device to tissue
- A61B2018/00279—Anchoring means for temporary attachment of a device to tissue deployable
- A61B2018/00285—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00404—Blood vessels other than those in or around the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00434—Neural system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00505—Urinary tract
- A61B2018/00511—Kidney
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00613—Irreversible electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00875—Resistance or impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1266—Generators therefor with DC current output
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/128—Generators therefor generating two or more frequencies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1467—Probes or electrodes therefor using more than two electrodes on a single probe
Definitions
- This application is in the general field of therapeutic electrical energy delivery, and it pertains more specifically to electrical energy delivery in the context of ablation of nerves in the vascular or vessel walls of renal arteries or renal denervation, a therapeutic procedure that can lead to reduced hypertension in patients with high blood pressure.
- the ablation energy can be in the form of high voltage DC pulses that generate irreversible electroporation of cell membranes and destroy tissue locally for therapeutic purposes, or it can be applied as RF energy that generates thermal energy.
- the applied electric field at the membrane exceeds a threshold value, typically dependent on cell size, the electroporation is irreversible and the pores remain open, permitting exchange of material across the membrane and leading to apoptosis or cell death. Subsequently, the surrounding tissue heals in a natural process.
- an apparatus includes a flexible catheter shaft and at least one electrode pair.
- the flexible catheter shaft has an electrically insulating expandable member coupled thereto such that the expandable member surrounds a portion of the catheter shaft.
- the portion of the catheter shaft defines a lumen, and a surface of the catheter shaft defines a first opening and a second opening.
- the first opening and the second opening are each in fluid communication with the lumen.
- the expandable member is disposed between the first opening and the second opening to establish a pathway through the expandable member via the lumen.
- the electrode pair includes a first electrode and a second electrode. The first electrode is coupled to the catheter shaft between the first opening and the expandable member. The second electrode is coupled to the catheter shaft between the second opening and the expandable member.
- a method includes using the catheter device and systems for the selective and rapid application of DC voltage to produce electroporation ablation for renal denervation.
- an irreversible electroporation system includes a DC voltage/signal generator and a controller for triggering voltage pulses to be applied to a selected multiplicity or a subset of electrodes.
- the catheter device has a set of electrodes for ablation or delivery of voltage pulses, and an expandable member (e.g., an inflatable balloon) disposed between a pair of electrodes. When the expandable member is moved to an expanded configuration (e.g., the balloon is inflated), the electrodes are positioned in the central region of the vessel lumen, away from the vessel wall.
- the catheter has openings from the exterior surface into an internal lumen that runs along a path approximately parallel to the longitudinal axis of the balloon, and with a lumen length that extends beyond either electrode of the electrode pair.
- the internal lumen provides an internal path in the device for blood flow through the renal vessel.
- the internal blood path also provides a shunt path for electric current to flow through when the electrodes on either end of the balloon are polarized.
- This shunt path for electric current also serves to reduce electric field intensities in corner regions between the balloon and the vessel wall, suppressing or eliminating local or regional hot spots where large current density values can drive local thermal heating of vascular tissue, resulting in a safer and more effective ablation device.
- the intense electric field near or in the internal vessel wall is reduced and/or eliminated, reducing the likelihood of vessel wall perforation.
- the electric field magnitude in the vessel wall can remain large enough to generate irreversible electroporation of the renal nerve endings therein.
- the catheter device has a set of electrodes for ablation or delivery of voltage pulses, at least one member of which is recessed from the outer surface such that when inserted in a vascular structure, it cannot directly contact the inner vascular wall.
- the recessed electrode contacts blood in the vessel, with blood forming a portion of the electrical path between anode and cathode electrodes, and with the vascular wall also forming a portion of the electrical path between anode and cathode electrodes.
- all of the electrodes on the catheter are recessed so that there is no direct physical contact between any of the electrodes and the vascular wall. Thus, the intense electric field near the electrode surface is removed from the wall, reducing or eliminating the likelihood of vessel wall perforation.
- At least one pair of anode and cathode electrodes are set in a recessed void in the catheter, and separated from each other by an insulator.
- the catheter can have a multiplicity of such pairs of anode and cathode electrodes recessed in the catheter, so as to be able to ablate a longer region or length of arterial wall more conveniently.
- the voltage pulses can have pulse widths in the range of nanoseconds to hundreds of microseconds. In some embodiments, there could be a multiplicity of such voltage pulses applied through the electrodes, with an interval between pulses that can for illustrative purposes be in the range of nanoseconds to hundreds of microseconds.
- the generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or multiphasic forms and with either constant or progressively changing amplitudes.
- FIG. 1 illustrates the placement of a catheter device according to an embodiment in the renal arteries for the purpose of renal denervation.
- FIG. 2 is a schematic illustration of a catheter assembly according to an embodiment showing an expandable member on a catheter shaft with electrodes disposed on the shaft near the ends of the expandable member, and showing openings in the catheter shaft into an internal device lumen that provides a blood path for blood flow.
- FIG. 3 is a side view of a catheter assembly according to an embodiment showing the catheter shaft, expandable member, and electrodes.
- FIG. 4 is a schematic cutaway view of a catheter assembly according to an embodiment in a central longitudinal plane of the catheter with the plane passing through the longitudinal axis of the catheter, and showing the distal portion of the catheter with expanded member inside a blood vessel with a vessel wall and a blood pool in the annular space between the catheter and the vessel wall, together with blood path through the catheter.
- FIG. 5 illustrates a finite element analysis-derived spatial intensity plot of electric voltage or potential within a three dimensional geometry including the catheter assembly of FIG. 4 with expanded member and a blood path when a defined electric potential difference is applied between the electrodes of the catheter.
- FIG. 6 depicts a finite element analysis-derived spatial quiver plot of current density within a finite element geometry similar to that of FIG. 4 , but without a blood path through the catheter, when a defined electric potential difference is applied between the electrodes of the catheter.
- FIG. 7 depicts a finite element analysis-derived spatial quiver plot of current density within the finite element geometry of FIG. 4 including a blood path through the catheter, when a defined electric potential difference is applied between the electrodes of the catheter.
- FIG. 8 illustrates a finite element analysis-derived spatial intensity plot of electric field within a three dimensional geometry including a catheter of the present invention with expanded member and a blood path, when a defined electric potential difference is applied between the electrodes of the catheter.
- FIG. 9 A is an illustration of a balloon catheter according to an embodiment in a renal vessel and showing a line segment along the inner vessel wall along which electric field intensity values can be plotted.
- FIG. 9 B is a graph plotting the variation of electric field intensity along the line segment of FIG. 9 A .
- FIG. 10 is an illustration of a catheter embodiment showing a recessed void in the exterior surface of the catheter wherein electrodes are disposed.
- FIG. 11 is a schematic cross-sectional view of a catheter embodiment in a central longitudinal plane of the catheter with the plane passing through the longitudinal axis of the catheter.
- FIG. 12 is a schematic cross-sectional view of the catheter shown in FIG. 11 disposed inside a blood vessel with a vessel wall.
- FIG. 13 illustrates the three dimensional geometry of a catheter embodiment with recessed electrodes, the catheter placed within a blood vessel with a vessel wall and a blood pool in the annular space of the blood vessel.
- FIG. 14 illustrates a finite element analysis-derived spatial intensity plot of electric voltage within a catheter according to an embodiment.
- FIG. 15 depicts a finite element analysis-derived spatial intensity plot of electric field within a catheter according to an embodiment when a defined electric potential difference is applied between the electrodes of the catheter.
- FIG. 16 shows a line plot of electric field intensity along a line perpendicular to the longitudinal axis of the catheter and passing along a transverse edge of one of the recessed catheter electrodes.
- FIG. 17 shows a catheter device according to an embodiment with a multiplicity of anode-cathode electrode sets disposed along a distal length of device.
- FIG. 18 schematically represents an irreversible electroporation system that together with a catheter device disclosed herein provides a therapeutic system for renal denervation ablation.
- FIG. 19 is a schematic illustration of a waveform generated by the irreversible electroporation system that can be used with a catheter device disclosed herein, showing a balanced square wave.
- FIG. 20 is a schematic illustration of a waveform generated by the irreversible electroporation system that can be used with a catheter device disclosed herein, showing a balanced biphasic square wave.
- FIG. 21 is a schematic illustration of a waveform generated by the irreversible electroporation system that can be used with a catheter device disclosed herein, showing a progressive balanced biphasic square wave.
- the irreversible electroporation system described herein includes a DC voltage pulse/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity of electrodes.
- the catheter has an inflatable balloon or similar expandable member disposed in its distal portion such that the catheter shaft passes through the balloon.
- the catheter has at least one anode-cathode pair of electrodes that are disposed on either end of the expandable member or inflatable balloon in the distal region of the catheter. With the balloon inflated, the electrodes are positioned in the central region of the vessel lumen and away from the vessel wall.
- the catheter has openings from the exterior surface into an internal lumen that runs along a path approximately parallel to the longitudinal axis of the catheter/balloon, and with a lumen length that extends beyond either electrode of the electrode pair.
- the internal lumen provides an internal path for blood flow in the device starting from a location proximal to the proximal electrode and ending at a location distal to the distal electrode, thus shunting blood flowing through the renal vessel.
- the balloon when the balloon is inflated and blocks most of the vessel lumen, blood can still flow from one end of the balloon to the other through the internal blood path in the catheter. Thus, vessel occlusion of blood flow does not occur.
- the internal blood path also provides a shunt path for electric current to flow through when the electrodes on either end of the balloon are polarized by an applied potential difference.
- This shunt path for electric current also serves to reduce electric field intensities in corner regions between the balloon and the vessel wall, suppressing or eliminating local or regional hot spots where large current density values can drive local thermal heating of vascular tissue, thereby resulting in an overall safer and more effective ablation device.
- the intense electric field and associated large current density near or in the internal vascular wall is eliminated, reducing the likelihood of vessel wall perforation.
- the voltage pulses can have pulse widths in the range of nanoseconds to hundreds of microseconds. In some embodiments, there could be a multiplicity of such voltage pulses applied through the electrodes, with an interval between pulses that can for illustrative purposes be in the range of nanoseconds to hundreds of microseconds.
- the generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or multiphasic forms and with either constant or progressively changing amplitudes.
- the balloons and/or expandable members described herein can be constructed from any suitable material.
- the balloon is made of a material that is electrically an insulator such as for example polyurethane.
- an apparatus in some embodiments, includes a flexible catheter shaft and at least one electrode pair.
- the flexible catheter shaft has an electrically insulating expandable member coupled thereto such that the expandable member surrounds a portion of the catheter shaft.
- the portion of the catheter shaft defines a lumen, and a surface of the catheter shaft defines a first opening and a second opening.
- the first opening and the second opening are each in fluid communication with the lumen.
- the expandable member is disposed between the first opening and the second opening to establish a pathway through the expandable member via the lumen.
- the electrode pair includes a first electrode and a second electrode.
- the first electrode is coupled to the catheter shaft between the first opening and the expandable member.
- the second electrode is coupled to the catheter shaft between the second opening and the expandable member.
- a method includes inserting a catheter device comprising a flexible catheter shaft and at least one electrode pair into a renal artery.
- the flexible catheter shaft has an electrically insulating expandable member coupled thereto such that the expandable member surrounds a portion of the catheter shaft.
- the expandable member is expanded until in expanded form it abuts the arterial vessel wall around its circumference, thereby positioning the catheter device so that it becomes well-centered within the vessel lumen.
- the portion of the catheter shaft surrounded by the expandable member defines a lumen, and a surface of the catheter shaft defines a first opening and a second opening each in fluid communication with the lumen.
- the first and second openings in the catheter shaft surface and the lumen together provide a path for blood flow to continue in the arterial vessel, even when the expanded member occludes longitudinal blood flow in the circumferential portions of the vessel cross section.
- a voltage pulse for tissue ablation is applied between the electrodes of the electrode pair, ablating the nerve endings in the renal arterial wall.
- the expandable member is relaxed or returned to unexpanded form, and the catheter device is inserted further into the renal arterial vessel for ablation at a subsequent location, and so on.
- the iterative steps of inserting and positioning the catheter device and applying ablation are continued as needed until the user decides that a sufficient degree of ablation has been applied.
- FIG. 1 An anatomical pathway and context for use of the catheter device according to an embodiment in a renal denervation ablation procedure is illustrated in FIG. 1 , illustrating the placement of a catheter device in the renal arteries for this purpose.
- FIG. 1 depicts a left (patient left) kidney 135 and a right kidney 134 together with left renal artery 132 and right renal artery 131 .
- Any of the catheter devices shown and described herein can be inserted into the vascular anatomy via, for example, femoral access and the distal portion 137 of the catheter is shown disposed within right renal artery 131 .
- Ablation pulses are applied at such a location or at a multiplicity of similar locations in the renal artery to destroy renal nerve endings in the vessel wall of the renal artery.
- FIG. 2 A catheter assembly according to an embodiment is illustrated in FIG. 2 in schematic form showing an expanded member (for purposes of non-limiting example, one form of the expanded member can be an inflated catheter balloon) on a catheter shaft with electrodes disposed on the shaft near the ends of the balloon.
- the distal portion of the catheter 346 has an inflatable balloon 348 disposed between proximal electrode 350 and distal electrode 351 located on either side (forward or backward along the device longitudinal axis) of the balloon.
- the electrodes are disposed with conducting surfaces exposed to the blood flow.
- the electrodes could be, for example, in the form of ring electrodes mounted on the catheter shaft and attached by an etching and gluing process, or swaged or crimped in place, or otherwise mounted by any of a range of processes known to those skilled in the art.
- an internal lumen for blood flow is present in the device between internal lumen end sections 356 and 357 .
- the catheter shaft has openings 353 and 354 respectively proximal to electrode 350 and electrode 351 so that blood flowing in the renal vessel can flow into the catheter internal lumen at one opening and out of the internal catheter lumen back into the renal vessel at the other opening, thus providing a shunt path for blood flow even when the balloon is inflated and is occluding most of the vessel cross section.
- the blood path also offers advantages in terms of distribution of electric field when a voltage difference is applied between the electrodes for pulsed high voltage delivery.
- the distal tip of the catheter can be rounded gently or tapered and rounded so as to present a smooth, blunt distal tip profile.
- a catheter device 400 is shown in a more detailed illustration (not to scale) in FIG. 3 .
- the distal portion of the catheter shaft 401 has an inner lumen 403 that runs from the proximal catheter end (not shown) to the distal portion, for delivery of pressurized air or fluid (such as, for example, saline) that may be utilized to inflate the balloon.
- the lumen 403 starts from a cut plane or section AI and runs up to approximately the proximal end of the balloon (denoted by section C 1 ), where it expands to fill a larger eccentric annular space within the catheter with openings (indicated by the small dotted ellipses such as 415 and 416 ) on the shaft that open into the balloon.
- the catheter has a shorter inner lumen 409 providing a blood path, with ends indicated by the reference characters 406 and 407 .
- This inner lumen has proximal and distal openings 353 and 354 , respectively, to the exterior lateral surface of the catheter, so that blood (which has a flow direction in the renal vessel from proximal to distal along the catheter when the catheter is inserted into the renal vessel as indicated in FIG. 1 ) can enter at one opening (for example, 353 ), flow inside the inner lumen 409 and exit through the other opening (for example, 354 ).
- electrodes in the form of rings 350 and 351 are indicated as mounted on the catheter shaft near proximal and distal ends respectively of the balloon 348 .
- the electrodes 350 , 351 can have any suitable size and/or shape.
- the electrodes 450 , 451 can be a ring-shaped electrode having a width in the range 1 mm-6 mm, and a diameter in the range of about 1 mm to about 6 mm.
- the nearest edge-to-edge separation between electrodes can be in the range from about 3 mm to about 25 mm.
- segmental pieces AI-B 1 , B 1 -C 1 , CI-D 1 , and DI-E 1 with distinct and suitably mating lumen structures can comprise polymeric material, be extruded separately and joined by processes such as heat bonding that are well known to those skilled in the art.
- Various polymeric materials can be used in the construction; for example, the balloon can be made of thin polyurethane with suitable stretchability (or compliance) for inflation.
- the catheter shaft can comprise polymers such as Teflon, polyurethane, Nylon, PEEK (Poly Ester Ester Ketone) or polyethylene that are utilized frequently in the medical device industry and known to one skilled in the art.
- the balloon 348 (and any of the balloons or expanded members described herein) can have a length in the range 3 mm-25 mm and an inflated diameter in the range 2 mm-6 mm. It is to be noted that in alternate embodiments, the inflatable balloon 348 (and any of the balloons or expanded members described herein) can instead be in the form of an expandable member, whether in the form of an expanded structure with a mesh-based unfolding structure, or a variety of other forms known to those skilled in the art. In the latter case the expandable member can have an expanded diameter in the range of about 2 mm to about 6 mm and a length in the range 3 mm-25 mm.
- the catheter shaft can also include metallic mesh or braid constructions in the wall for torque transmission and suitable rigidity.
- the electrodes can include metals such as Platinum Iridium alloy, stainless steel, silver or other biocompatible metals that are known in the medical device industry as suitable electrode materials, and may be affixed to the catheter by an etching and gluing process, swaging, crimping or other processes known to one skilled in the art.
- the electrodes have leads attached to the inner or non-exposed side that run back to the catheter handle for connection to an appropriate electrical connector (not shown in FIG. 3 ).
- the diameter of the catheter can be in the approximate range 0.8 mm-4 mm. While the materials and methods mentioned here are for illustrative purposes, it should be appreciated that those skilled in the art can conceive of the use of a variety of other materials and construction methods.
- FIG. 4 A schematic cutaway view of a catheter 13 according to an embodiment is shown in FIG. 4 in a central longitudinal plane of the catheter with the plane passing through the longitudinal axis of the catheter, and showing the distal portion of the catheter with inflated balloon inside a blood vessel with a vessel wall and a blood pool in the annular space between the catheter and the vessel wall, together with blood path through the catheter.
- the distal portion of the catheter 13 has a balloon 11 disposed on it, said balloon being inflated within a renal vessel with a thin vascular wall 12 .
- the balloon includes an electrical insulator, for example in the form of a mechanically compliant polymer such as polyurethane. Electrodes 15 on either end of the balloon can be polarized with an electrical voltage or potential difference.
- Flowing blood pool 19 is present in the renal vessel, enters the inner catheter lumen through opening 14 in the catheter wall and exits the inner lumen through opening 141 .
- either of the electrodes 15 can serve as anode, with the other member of the pair then taking on the role of cathode.
- Electrical leads (not shown) passing through a hollow lumen in the catheter connect to the respective electrodes for voltage delivery.
- the electrical leads are provided with suitable high dielectric strength insulation utilizing a suitable material such as for example Teflon.
- the material and thickness of the high dielectric strength insulation is chosen so that it can withstand a voltage of at least 500 Volts in the electrical conductor of the lead without dielectric discharge or breakdown.
- the geometry shown can be used in a computational model with appropriate physical parameters (such as electrical conductivities) assigned to blood, tissue, metal and insulator to compute the electric potential and field in the spatial region around the catheter when a voltage or potential difference is applied between the electrodes.
- appropriate physical parameters such as electrical conductivities assigned to blood, tissue, metal and insulator to compute the electric potential and field in the spatial region around the catheter when a voltage or potential difference is applied between the electrodes.
- FIG. 5 Such a simulation result is shown in FIG. 5 in the form of a shaded intensity plot for the electric potential, when the proximal electrode 15 has a high potential (500 Volts) and the distal electrode 151 is assigned a low potential (ground or zero voltage).
- FIG. 5 also indicates the catheter shaft 13 , openings 14 and 141 in the catheter for access to the blood path, the balloon 11 and the vessel wall 10 .
- the indicated contours 160 , 152 , 153 , and 162 (marked by dashed contour lines in FIG.
- FIG. 6 A finite element analysis-derived spatial quiver plot of current density within a finite element geometry similar to that of FIG. 4 but without a blood path through the catheter is depicted in FIG. 6 .
- the arrows in the quiver plot indicate the local direction of the current density vector and the arrow length indicates the magnitude of local current density when a defined electric potential difference is applied between the electrodes of the catheter, with electrode 15 at a high potential and electrode 151 at a low potential.
- the catheter shaft is indicated as 13 and the vessel wall 12 is also labeled in the FIG. along with the balloon 11 .
- the current density exits electrode 15 and enters electrode 151 with the potential difference applied between the electrodes. It can be noted that there is a significant magnitude of current density 17 at or near the vessel wall, determined from the simulation to correspond to an electric field intensity or magnitude of over 1260 Volts/cm.
- FIG. 7 depicts a finite element analysis-derived spatial quiver plot of current density within the finite element geometry of FIG. 4 including a blood path through the catheter, again with the arrows in the quiver plot indicating the local direction of the current density vector and the arrow length indicating magnitude of local current density when a defined electric potential difference is applied between the electrodes of the catheter, with electrode 15 at a high potential and electrode 151 at a low potential.
- the catheter shaft is indicated as 13 and the vessel wall 12 is also labeled in the FIG. along with the balloon 11 .
- the current density exits electrode 15 and enters electrode 151 with the potential difference applied between the electrodes. It can be noted that the magnitude of current density 23 at or near the vessel wall is now very small.
- FIG. 8 illustrates a finite element analysis-derived spatial intensity plot of electric field within a three dimensional geometry including a catheter according to an embodiment with an inflated balloon and a blood path, the catheter placed within a blood vessel with a vessel wall and a blood pool in the annular space between the catheter and the vessel wall (i.e., the same configuration as is shown in FIG. 7 ).
- FIG. 8 shows a shaded intensity plot when a defined electric potential difference is applied between the electrodes of the catheter, with electrode 15 at a high potential and electrode 151 at a low potential.
- the catheter shaft is indicated as 13 and the vessel wall 12 is also labeled in FIG. 8 along with the balloon 11 .
- the shaded area represents the region where the electric field intensity is approximately 500 V/cm, suitable for the irreversible electroporation of renal nerve endings in the vessel wall, and it can be seen as indicated by 41 that the vessel wall has an appropriate electric field intensity for ablation.
- Regions with very high intensity electric fields have been effectively moved away from the interior of the vessel wall.
- a similar catheter device without a blood path generates electric field intensities of over 1260 Volts/cm at the vessel wall.
- FIG. 9 A shows a portion of the balloon catheter with balloon 11 and electrode 151 disposed in a vessel with arterial walls 12 .
- a longitudinal line 145 of length 1 cm centered at the point of contact 144 of the balloon with the wall (and with the line 145 disposed at the inner surface of the vessel wall) is used as a line along which electric field intensity is plotted in FIG. 9 B .
- the peak value 146 of electric field intensity along the line 145 of FIG. 9 A substantially drops from a value of approximately 1200 V/cm to a value 147 of 500 V/cm within about 1 mm.
- the catheter has at least one anode-cathode pair of electrodes that are recessed from the exterior surface of the distal region of the catheter.
- the electrodes With the electrodes positioned away in a radially inward manner from the diameter profile of the cross section of the catheter, the electric field generated due to an applied potential difference between the electrodes is not excessively large at the arterial wall, thus preserving the wall itself.
- the nerve cells in the nerves present in the vascular wall are in the presence of an electric field large enough to generate irreversible electroporation and subsequent cell necrosis.
- the recessed electrodes contact blood in the vessel, with blood thus forming a portion of the electrical path between anode and cathode electrodes.
- the vascular wall also forms a portion of the electrical path between anode and cathode electrodes.
- all the electrodes on the catheter are recessed so that there is no direct physical contact between any of the electrodes and the vascular wall.
- the intense electric field near the electrode surface is removed from the wall, reducing or eliminating the likelihood of vessel wall perforation while the electric field is still large enough to generate irreversible electroporation of the renal nerve endings therein.
- a pair of anode and cathode electrodes are set in a recessed void in the catheter, and separated from each other by an insulator.
- the voltage pulses can for exemplary purposes have pulse widths in the range of tens to hundreds of microseconds. In some embodiments there could be a multiplicity of such voltage pulses applied through the electrodes, with an interval between pulses that can for illustrative purposes be in the range of tens to hundreds of microseconds.
- the generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or multiphasic forms and with either constant or progressively changing amplitudes.
- FIG. 10 A catheter according to an embodiment having a recessed void in the exterior surface of the catheter, wherein recessed electrodes are disposed therein for applying electrical voltages for ablation purposes, is shown in FIG. 10 .
- the distal portion 511 of the catheter body has a recessed void 512 where electrodes are located, with anode and cathode electrodes on diametrically opposite sides of the catheter's central longitudinal axis.
- the distal tip of the catheter can be rounded gently or tapered and rounded (not shown in FIG. 10 ) so as to present a smooth, blunt distal tip profile.
- FIG. 11 shows a schematic cross-sectional view of a catheter 511 in a central longitudinal plane of the catheter with the plane passing through the longitudinal axis of the catheter.
- the catheter body 511 has a recess or void 512 , within which are located metallic or electrically conducting electrodes 21 disposed on either side of an electrical insulator 522 .
- the catheter body can be made of Teflon, polyurethane, Nylon, PEEK (Polyether Ether Ketone), polyethylene or any of a range of polymers commonly used in the medical device industry to build catheter devices and known to those skilled in the art.
- the diameter of the catheter can be in the approximate range 0.8 mm-4 mm.
- the void or recess can have a length dimension in the range 0.5 mm-5 mm and a width dimension in the range 0.2 mm-2 mm at the exterior catheter surface, while having a recess or depth dimension in the approximate range 0.5 mm-1.5 mm measured radially inward from the surface.
- the ratio of recess depth to catheter diameter can be in the range 0.1 to 0.45.
- the metallic electrodes can comprise biocompatible materials such as platinum iridium, stainless steel, silver or a range of other conductors familiar to one skilled in the art.
- the void can be fabricated by machining, drilling, punching or molding.
- the insulator between the electrodes can comprise materials such as Teflon or polyurethane that are known to have a high dielectric strength.
- the electrodes and insulator between the electrodes can be positioned by etching the catheter and held in place by a suitable gluing process.
- FIG. 11 shows a rectangular geometry for the electrodes and flat surfaces for the recess walls
- more general shapes could be used in other embodiments.
- ellipsoidal electrodes disposed in a recess with either flat or curved walls, approximately spherical or ellipsoidal recess walls, and so on can be used in some embodiments.
- approximately rectangular parallelepiped electrodes are disposed in the catheter, with edges and corners rounded to result in gently curving forms in order to reduce or eliminate areas of high curvature, which can result in further reductions in electric field intensity distributions.
- FIG. 12 illustrates a schematic cutaway view of a catheter according to an embodiment along a central longitudinal plane of the catheter with the plane passing through the longitudinal axis of the catheter, and showing the catheter inside a blood vessel with a vessel wall 531 and a blood pool 532 disposed in the annular space between the catheter and the vessel wall, together providing a geometry for finite element analysis.
- the recess or void 512 in the catheter body, and the electrically conducting electrodes 521 within the void are indicated along with the electrical insulator 522 disposed between the electrodes 521 .
- either of the electrodes 521 can serve as anode, with the other member of the pair then taking on the role of cathode.
- the electrical leads passing through a hollow lumen in the catheter connect to the respective electrodes for voltage delivery.
- the electrical leads are provided with suitable high dielectric strength insulation utilizing a suitable material such as for example Teflon; the material and thickness of the high dielectric strength insulation is chosen so that it can withstand a voltage of at least 500 Volts in the electrical conductor of the lead without dielectric discharge or breakdown. In an alternate embodiment, the high dielectric strength insulation is chosen so that it can withstand a voltage of at least 2000 Volts in the electrical conductor of the lead without dielectric discharge or breakdown.
- FIG. 13 The three dimensional geometry of the catheter with the recessed electrodes within a blood vessel filled with blood is further illustrated in FIG. 13 , where the inner cylinder represents the catheter shaft 511 within a blood vessel illustrated by vessel wall 531 and with blood 532 disposed in the annular space between the catheter shaft and the vessel wall.
- the electrodes 512 and insulator 522 between the electrodes are indicated within the catheter body.
- This geometry can be used in a computational model with appropriate physical parameters (such as electrical conductivities) assigned to blood, tissue, metal and insulator to compute the electric potential and field in the spatial region around the catheter when a voltage or potential difference is applied between the electrodes.
- FIG. 14 Such a simulation result is shown in FIG. 14 in a longitudinal section view in the form of a contour plot for the electric potential, when the top electrode 521 in the FIG. is assigned a high potential and the bottom electrode is assigned a low potential.
- the high and low potentials were set at 500 Volts and zero respectively.
- the electric potential was directly solved for in the computational model, and its negative gradient (the electric field vector) was evaluated.
- contours 590 , 591 and 592 correspond to isopotential lines at 500 Volts, 400 Volts and 300 Volts respectively.
- the magnitude of the electric field, or the electric field intensity is displayed in FIG. 15 in a longitudinal section view, also in the form of a contour plot.
- This plot shows electric field intensity contours 561 , 562 and 563 at magnitudes of 2000 Volts/cm, 1000 Volts/cm and 500 Volts/cm respectively. It can be seen that there are high intensity electric fields 561 (approximately 2000 Volts/cm) near corners of the recess at the catheter surface, whereas outside the catheter, and in regions 531 in the arterial vessel wall, the electric field intensity 563 is significantly lower (approximately 500 Volts/cm). Thus, the very high electric field regions have been effectively moved away from the vessel wall. The electric field distribution with the same potential difference of 500 Volts between the electrodes is further clarified in FIG.
- FIG. 16 which provides a line plot of electric field intensity along a line perpendicular to the catheter's longitudinal axis and along one of the transverse edges of the electrodes.
- the plot therein shows the line plot along line 620 , with the top portion of the FIG. (above the peaks in the plot) representing a rotated version of a portion of the contour plot of FIG. 15 .
- electrodes 521 are visible along with arterial wall 531 (now running in the vertical direction in the top portion of FIG. 16 ).
- contour 571 corresponding to an electric field magnitude of approximately 14,000 Volts/cm).
- Contours 572 and 573 correspond to electric field magnitudes of approximately 8,600 Volts/cm and 2,900 Volts/cm respectively. Proceeding along line 620 from left to right in the FIG., the graphical plot in the lower portion of FIG. 16 shows that the electric field intensities 624 and 622 at the arterial wall are substantially reduced (they have an approximate value of 500 Volts/cm, a safe level in tissue) in comparison with the peak value 625 that occurs near inner corners of the electrode. In particular, the electric field in the tissue wall of the vessel is large enough to generate irreversible electroporation therein without being large enough to cause a thermal hot spot.
- FIG. 17 An embodiment of the catheter device according to an embodiment with two pairs of anode-cathode ablation electrodes in the distal portion of the device is illustrated in FIG. 17 , which shows the distal portion 746 of the catheter device within a renal artery 745 . While two pairs or sets of electrodes are shown in this illustration, in other embodiments, any number of electrodes can be disposed in the device without limitation.
- FIG. 17 shows a distal electrode set 748 with electrodes 752 and 753 separated by an electrically insulating region 755 . Also shown is a proximal electrode set 749 . Electrical leads 758 and 759 connect to electrodes 752 and 753 respectively while electrical leads 761 and 762 connect to respective electrodes of electrode set 749 .
- the electrical leads are provided with suitable high dielectric strength insulation utilizing a suitable material such as for example Teflon; the material and thickness of the high dielectric strength insulation is chosen so that it can withstand a voltage of at least 500 Volts in the electrical conductor of the lead without dielectric discharge or breakdown. In an alternate embodiment the high dielectric strength insulation is chosen so that it can withstand a voltage of at least 2000 Volts in the electrical conductor of the lead without dielectric discharge or breakdown.
- FIG. 18 A schematic representation of an irreversible electroporation system is depicted in FIG. 18 , and together with the catheter device disclosed herein it provides a complete therapeutic system for renal denervation ablation.
- a DC voltage/signal generator 73 is driven or triggered by a controller unit 71 that interfaces with a computer device 74 by means of a two-way communication link 79 .
- the controller can perform channel selection and routing functions for applying DC voltages to appropriate electrodes that have been selected by a user or by the computer 74 , and apply the voltages via a multiplicity of leads (shown collectively as 80 ) to a catheter device 72 .
- the controller can also record and display impedance data from at least a pair of the electrodes of the catheter device 72 .
- Such impedance data could for instance be used to determine suitable arterial locations for ablation.
- the DC voltage generator 73 sends a DC voltage to the controller 71 through high voltage leads 77
- the voltage generator is triggered by control and timing inputs 78 from the controller unit 71 .
- the computer 74 is integrated with the controller 71 in a single enclosure.
- a user interface for the system can comprise multiple elements such as, for non-limiting purposes, a graphical display, a push button, foot pedal or joystick for user-triggered ablation application, a touch screen interface, or any of a variety of such interfaces that are familiar to those skilled in the art and as may be convenient for implementation and for user interaction in the context of the medical application.
- a DC voltage for electroporation can be applied to the catheter electrodes.
- the DC voltage is applied in brief pulses sufficient to cause irreversible electroporation can be in the range of 0.5 kV to 10 kV and more preferably in the range 1 kV to 4 kV, so that an appropriate threshold electric field is effectively achieved in the renal nerve tissue to be ablated.
- the electrodes marked for ablation can be automatically identified, or manually identified by suitable marking, on an X-ray or fluoroscopic image obtained at an appropriate angulation that permits identification of the geometric distance between anode and cathode electrodes, or their respective centroids.
- the DC voltage generator setting for irreversible electroporation is then automatically identified by the electroporation system based on this distance measure.
- the DC voltage value is selected directly by a user from a suitable dial, slider, touch screen, or any other user interface.
- the DC voltage pulse results in a current flowing between the anode and cathode electrodes, with said current flowing through the blood in the renal artery, the blood path through the catheter lumen, and the vessel wall tissue, with the current flowing from the anode and returning back through the cathode electrode.
- the forward and return current paths (leads) are both inside the catheter.
- the controller and generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic or more generally, multiphasic forms and with either constant or progressively changing amplitudes.
- FIG. 19 shows a rectangular wave pulse train where the pulses 101 have a uniform height or maximum voltage.
- FIG. 20 shows an example of a balanced biphasic rectangular pulse train, where each positive voltage pulse such as 103 is immediately followed by a negative voltage pulse such as 104 of equal amplitude and opposite sign. While in this example the biphasic pulses are balanced with equal amplitudes of the positive and negative voltages, in other embodiments an unbalanced biphasic waveform could also be used as may be convenient for a given application.
- FIG. 21 shows a progressive balanced rectangular pulse train, where each distinct biphasic pulse has equal-amplitude positive and negative voltages, but each pulse such as 107 is larger in amplitude than its immediate predecessor 106 .
- FIG. 21 shows a progressive balanced rectangular pulse train, where each distinct biphasic pulse has equal-amplitude positive and negative voltages, but each pulse such as 107 is larger in amplitude than its immediate predecessor 106 .
- Other variations such as a progressive unbalanced rectangular pulse train, or indeed a wide variety of other variations of pulse amplitude with respect to time can be conceived and implemented by those skilled in the art based on the teachings herein.
- the time duration of each irreversible electroporation rectangular voltage pulse could lie in the range from 1 nanosecond to 10 milliseconds, with the range 10 microseconds to 1 millisecond being more preferable and the range 50 microseconds to 300 microseconds being still more preferable.
- the time interval between successive pulses of a pulse train could be in the range of 1 nanosecond to 1 millisecond, with the range 50 microseconds to 300 microseconds being more preferable.
- the number of pulses applied in a single pulse train (with delays between individual pulses lying in the ranges just mentioned) can range from 1 to 100, with the range 1 to 10 being more preferable.
- a pulse train can be driven by a user-controlled switch or button, in one embodiment mounted on a hand-held joystick-like device while in an alternate embodiment it could be in the form of a foot pedal and in still another embodiment it could be implemented with a computer mouse. Indeed a variety of such triggering schemes can be implemented by those skilled in the art, as convenient for the application and without departing from the scope of the present invention.
- a pulse train can be generated for every push of such a control button, while in an alternate mode of operation pulse trains can be generated repeatedly for as long as the user-controlled switch or button is engaged by the user.
- a multiplicity of electrodes could be located proximal to the balloon and a multiplicity of electrodes could be located distal to the balloon.
- a device can include an expandable member similar to the expanded member shown and described with reference to FIGS. 2 and 3 along with a recessed electrode similar to the recessed electrodes shown and described with reference to FIGS. 11 through 13 .
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plasma & Fusion (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Otolaryngology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Surgical Instruments (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
- This application is a continuation of U.S. patent application Ser. No. 16/719,708, filed Dec. 18, 2019, entitled APPARATUS AND METHODS FOR RENAL DENERVATION ABLATION, now U.S. Pat. No. 11,589,919, which is a divisional of U.S. patent application Ser. No. 15/201,997 filed Jul. 5, 2016, entitled “APPARATUS AND METHODS FOR RENAL DENERVATION ABLATION,” now U.S. Pat. No. 10,517,672, which is a continuation of PCT/US2015/010223 filed Jan. 6, 2015, entitled “APPARATUS AND METHODS FOR RENAL DENERVATION ABLATION,” which claims priority to and the benefit of U.S. Provisional Application No. 61/923,969 filed Jan. 6, 2014, entitled “BALLOON CATHETER WITH BLOOD PATH,” and U.S. Provisional Application No. 61/923,966 filed Jan. 6, 2014, entitled “OFFSET RENAL DENERVATION ELECTRODE,” all of which are incorporated by reference herein in their entirety.
- This application is in the general field of therapeutic electrical energy delivery, and it pertains more specifically to electrical energy delivery in the context of ablation of nerves in the vascular or vessel walls of renal arteries or renal denervation, a therapeutic procedure that can lead to reduced hypertension in patients with high blood pressure. The ablation energy can be in the form of high voltage DC pulses that generate irreversible electroporation of cell membranes and destroy tissue locally for therapeutic purposes, or it can be applied as RF energy that generates thermal energy.
- The past two decades have seen advances in the technique of electroporation as it has progressed from the laboratory to clinical applications. Known methods include applying brief, high voltage DC pulses to tissue, thereby generating locally high electric fields, typically in the range of hundreds of Volts/centimeter. The electric fields disrupt cell membranes by generating pores in the cell membrane, which subsequently destroys the cell membrane and the cell. While the precise mechanism of this electrically-driven pore generation (or electroporation) awaits a detailed understanding, it is thought that the application of relatively large electric fields generates instabilities in the phospholipid bilayers in cell membranes, as well as mitochondria, causing the occurrence of a distribution of local gaps or pores in the membrane. If the applied electric field at the membrane exceeds a threshold value, typically dependent on cell size, the electroporation is irreversible and the pores remain open, permitting exchange of material across the membrane and leading to apoptosis or cell death. Subsequently, the surrounding tissue heals in a natural process.
- While pulsed DC voltages are known to drive electroporation under the right circumstances, the examples of irreversible electroporation applications in medicine and delivery methods described in the prior art do not provide specific means of limiting possible damage to nearby tissue while it is desired to ablate tissue relatively farther away. There is a need for selective energy delivery methods and devices that generate tissue ablation where it is desired, while leaving tissue elsewhere relatively intact and unchanged. In the specific context of minimally invasive renal denervation for the treatment of hypertension, known ablation devices are generally positioned in the renal arteries for electrical energy delivery to the renal artery walls. The outer layers of the renal arteries, or adventitia, have a distribution of renal nerve endings. When these nerve endings are destroyed by application of a high electric field, the consequent reduction in renal sympathetic activity can result in decreased hypertension. During this process, the vessel wall must be maintained intact; the local electric field in the vessel wall must not be too large, in order to avoid generating locally large current densities in the vessel wall which can lead to local thermal “hot spots” that can unintentionally damage or perforate the renal vessel. Thus it is desired to maintain vessel integrity and reduce and/or avoid local thermal hot spots driven by locally large current densities while still maintaining an electric field magnitude that is still above the threshold of irreversible electroporation.
- There is a need for selective energy delivery for electroporation in such a manner as to preserve overall vascular integrity while destroying the nerve endings in the adventitia of the renal artery where ablation is to be performed.
- The present disclosure addresses the need for tools and methods for rapid and selective application of electroporation therapy in the treatment of hypertension by minimally invasive ablation of the renal arteries. The embodiments described herein can result in well-controlled and specific delivery of electroporation in an efficacious manner while preserving vascular tissue where the local damage is to be preferentially minimized by reducing and/or eliminating thermal hot spots (or localized areas of high temperature and/or spatial temperature gradients), in order to maintain overall vascular integrity. In some embodiments, an apparatus includes a flexible catheter shaft and at least one electrode pair. The flexible catheter shaft has an electrically insulating expandable member coupled thereto such that the expandable member surrounds a portion of the catheter shaft. The portion of the catheter shaft defines a lumen, and a surface of the catheter shaft defines a first opening and a second opening. The first opening and the second opening are each in fluid communication with the lumen. The expandable member is disposed between the first opening and the second opening to establish a pathway through the expandable member via the lumen. The electrode pair includes a first electrode and a second electrode. The first electrode is coupled to the catheter shaft between the first opening and the expandable member. The second electrode is coupled to the catheter shaft between the second opening and the expandable member.
- In some embodiments, a method includes using the catheter device and systems for the selective and rapid application of DC voltage to produce electroporation ablation for renal denervation. For example, in some embodiments, an irreversible electroporation system includes a DC voltage/signal generator and a controller for triggering voltage pulses to be applied to a selected multiplicity or a subset of electrodes. The catheter device has a set of electrodes for ablation or delivery of voltage pulses, and an expandable member (e.g., an inflatable balloon) disposed between a pair of electrodes. When the expandable member is moved to an expanded configuration (e.g., the balloon is inflated), the electrodes are positioned in the central region of the vessel lumen, away from the vessel wall. Furthermore, the catheter has openings from the exterior surface into an internal lumen that runs along a path approximately parallel to the longitudinal axis of the balloon, and with a lumen length that extends beyond either electrode of the electrode pair. Thus, the internal lumen provides an internal path in the device for blood flow through the renal vessel. When the balloon is inflated and blocks most of the vessel lumen, blood can still flow from one end of the balloon to the other through the internal blood path in the catheter. Thus, vessel occlusion of blood flow does not occur. The internal blood path also provides a shunt path for electric current to flow through when the electrodes on either end of the balloon are polarized. This shunt path for electric current also serves to reduce electric field intensities in corner regions between the balloon and the vessel wall, suppressing or eliminating local or regional hot spots where large current density values can drive local thermal heating of vascular tissue, resulting in a safer and more effective ablation device. Thus, the intense electric field near or in the internal vessel wall is reduced and/or eliminated, reducing the likelihood of vessel wall perforation. The electric field magnitude in the vessel wall can remain large enough to generate irreversible electroporation of the renal nerve endings therein.
- In some embodiments, the catheter device has a set of electrodes for ablation or delivery of voltage pulses, at least one member of which is recessed from the outer surface such that when inserted in a vascular structure, it cannot directly contact the inner vascular wall. The recessed electrode contacts blood in the vessel, with blood forming a portion of the electrical path between anode and cathode electrodes, and with the vascular wall also forming a portion of the electrical path between anode and cathode electrodes. In some embodiments, all of the electrodes on the catheter are recessed so that there is no direct physical contact between any of the electrodes and the vascular wall. Thus, the intense electric field near the electrode surface is removed from the wall, reducing or eliminating the likelihood of vessel wall perforation. The electric field magnitude in the vessel wall, however, is large enough to generate irreversible electroporation of the renal nerve endings therein. In some embodiments, at least one pair of anode and cathode electrodes are set in a recessed void in the catheter, and separated from each other by an insulator. In general, the catheter can have a multiplicity of such pairs of anode and cathode electrodes recessed in the catheter, so as to be able to ablate a longer region or length of arterial wall more conveniently.
- In some embodiments, for example, the voltage pulses can have pulse widths in the range of nanoseconds to hundreds of microseconds. In some embodiments, there could be a multiplicity of such voltage pulses applied through the electrodes, with an interval between pulses that can for illustrative purposes be in the range of nanoseconds to hundreds of microseconds. The generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or multiphasic forms and with either constant or progressively changing amplitudes.
-
FIG. 1 illustrates the placement of a catheter device according to an embodiment in the renal arteries for the purpose of renal denervation. -
FIG. 2 is a schematic illustration of a catheter assembly according to an embodiment showing an expandable member on a catheter shaft with electrodes disposed on the shaft near the ends of the expandable member, and showing openings in the catheter shaft into an internal device lumen that provides a blood path for blood flow. -
FIG. 3 is a side view of a catheter assembly according to an embodiment showing the catheter shaft, expandable member, and electrodes. -
FIG. 4 is a schematic cutaway view of a catheter assembly according to an embodiment in a central longitudinal plane of the catheter with the plane passing through the longitudinal axis of the catheter, and showing the distal portion of the catheter with expanded member inside a blood vessel with a vessel wall and a blood pool in the annular space between the catheter and the vessel wall, together with blood path through the catheter. -
FIG. 5 illustrates a finite element analysis-derived spatial intensity plot of electric voltage or potential within a three dimensional geometry including the catheter assembly ofFIG. 4 with expanded member and a blood path when a defined electric potential difference is applied between the electrodes of the catheter. -
FIG. 6 depicts a finite element analysis-derived spatial quiver plot of current density within a finite element geometry similar to that ofFIG. 4 , but without a blood path through the catheter, when a defined electric potential difference is applied between the electrodes of the catheter. -
FIG. 7 depicts a finite element analysis-derived spatial quiver plot of current density within the finite element geometry ofFIG. 4 including a blood path through the catheter, when a defined electric potential difference is applied between the electrodes of the catheter. -
FIG. 8 illustrates a finite element analysis-derived spatial intensity plot of electric field within a three dimensional geometry including a catheter of the present invention with expanded member and a blood path, when a defined electric potential difference is applied between the electrodes of the catheter. -
FIG. 9A is an illustration of a balloon catheter according to an embodiment in a renal vessel and showing a line segment along the inner vessel wall along which electric field intensity values can be plotted. -
FIG. 9B is a graph plotting the variation of electric field intensity along the line segment ofFIG. 9A . -
FIG. 10 is an illustration of a catheter embodiment showing a recessed void in the exterior surface of the catheter wherein electrodes are disposed. -
FIG. 11 is a schematic cross-sectional view of a catheter embodiment in a central longitudinal plane of the catheter with the plane passing through the longitudinal axis of the catheter. -
FIG. 12 is a schematic cross-sectional view of the catheter shown inFIG. 11 disposed inside a blood vessel with a vessel wall. -
FIG. 13 illustrates the three dimensional geometry of a catheter embodiment with recessed electrodes, the catheter placed within a blood vessel with a vessel wall and a blood pool in the annular space of the blood vessel. -
FIG. 14 illustrates a finite element analysis-derived spatial intensity plot of electric voltage within a catheter according to an embodiment. -
FIG. 15 depicts a finite element analysis-derived spatial intensity plot of electric field within a catheter according to an embodiment when a defined electric potential difference is applied between the electrodes of the catheter. -
FIG. 16 shows a line plot of electric field intensity along a line perpendicular to the longitudinal axis of the catheter and passing along a transverse edge of one of the recessed catheter electrodes. -
FIG. 17 shows a catheter device according to an embodiment with a multiplicity of anode-cathode electrode sets disposed along a distal length of device. -
FIG. 18 schematically represents an irreversible electroporation system that together with a catheter device disclosed herein provides a therapeutic system for renal denervation ablation. -
FIG. 19 is a schematic illustration of a waveform generated by the irreversible electroporation system that can be used with a catheter device disclosed herein, showing a balanced square wave. -
FIG. 20 is a schematic illustration of a waveform generated by the irreversible electroporation system that can be used with a catheter device disclosed herein, showing a balanced biphasic square wave. -
FIG. 21 is a schematic illustration of a waveform generated by the irreversible electroporation system that can be used with a catheter device disclosed herein, showing a progressive balanced biphasic square wave. - This embodiments described herein include a catheter device and systems for renal denervation ablation with rapid application of DC high voltage pulses to drive irreversible electroporation. In some embodiments, the irreversible electroporation system described herein includes a DC voltage pulse/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity of electrodes.
- In some embodiments, the catheter has an inflatable balloon or similar expandable member disposed in its distal portion such that the catheter shaft passes through the balloon. The catheter has at least one anode-cathode pair of electrodes that are disposed on either end of the expandable member or inflatable balloon in the distal region of the catheter. With the balloon inflated, the electrodes are positioned in the central region of the vessel lumen and away from the vessel wall. Furthermore, the catheter has openings from the exterior surface into an internal lumen that runs along a path approximately parallel to the longitudinal axis of the catheter/balloon, and with a lumen length that extends beyond either electrode of the electrode pair. Thus, the internal lumen provides an internal path for blood flow in the device starting from a location proximal to the proximal electrode and ending at a location distal to the distal electrode, thus shunting blood flowing through the renal vessel. In this manner, when the balloon is inflated and blocks most of the vessel lumen, blood can still flow from one end of the balloon to the other through the internal blood path in the catheter. Thus, vessel occlusion of blood flow does not occur.
- Moreover, in some embodiments, the internal blood path also provides a shunt path for electric current to flow through when the electrodes on either end of the balloon are polarized by an applied potential difference. This shunt path for electric current also serves to reduce electric field intensities in corner regions between the balloon and the vessel wall, suppressing or eliminating local or regional hot spots where large current density values can drive local thermal heating of vascular tissue, thereby resulting in an overall safer and more effective ablation device. Thus, the intense electric field and associated large current density near or in the internal vascular wall is eliminated, reducing the likelihood of vessel wall perforation.
- The electric field magnitude in the vessel wall, however, can remain large enough to generate irreversible electroporation of the renal nerve endings therein and successful ablation results. In some embodiments, the voltage pulses can have pulse widths in the range of nanoseconds to hundreds of microseconds. In some embodiments, there could be a multiplicity of such voltage pulses applied through the electrodes, with an interval between pulses that can for illustrative purposes be in the range of nanoseconds to hundreds of microseconds. The generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or multiphasic forms and with either constant or progressively changing amplitudes.
- The balloons and/or expandable members described herein can be constructed from any suitable material. For example, in some embodiments, the balloon is made of a material that is electrically an insulator such as for example polyurethane.
- In some embodiments, an apparatus includes a flexible catheter shaft and at least one electrode pair. The flexible catheter shaft has an electrically insulating expandable member coupled thereto such that the expandable member surrounds a portion of the catheter shaft. The portion of the catheter shaft defines a lumen, and a surface of the catheter shaft defines a first opening and a second opening. The first opening and the second opening are each in fluid communication with the lumen. The expandable member is disposed between the first opening and the second opening to establish a pathway through the expandable member via the lumen. The electrode pair includes a first electrode and a second electrode. The first electrode is coupled to the catheter shaft between the first opening and the expandable member. The second electrode is coupled to the catheter shaft between the second opening and the expandable member.
- In some embodiments, a method includes inserting a catheter device comprising a flexible catheter shaft and at least one electrode pair into a renal artery. The flexible catheter shaft has an electrically insulating expandable member coupled thereto such that the expandable member surrounds a portion of the catheter shaft. The expandable member is expanded until in expanded form it abuts the arterial vessel wall around its circumference, thereby positioning the catheter device so that it becomes well-centered within the vessel lumen. The portion of the catheter shaft surrounded by the expandable member defines a lumen, and a surface of the catheter shaft defines a first opening and a second opening each in fluid communication with the lumen. With the expandable member in expanded form, the first and second openings in the catheter shaft surface and the lumen together provide a path for blood flow to continue in the arterial vessel, even when the expanded member occludes longitudinal blood flow in the circumferential portions of the vessel cross section. With the device thus deployed, a voltage pulse for tissue ablation is applied between the electrodes of the electrode pair, ablating the nerve endings in the renal arterial wall. Subsequently, the expandable member is relaxed or returned to unexpanded form, and the catheter device is inserted further into the renal arterial vessel for ablation at a subsequent location, and so on. The iterative steps of inserting and positioning the catheter device and applying ablation are continued as needed until the user decides that a sufficient degree of ablation has been applied.
- An anatomical pathway and context for use of the catheter device according to an embodiment in a renal denervation ablation procedure is illustrated in
FIG. 1 , illustrating the placement of a catheter device in the renal arteries for this purpose.FIG. 1 depicts a left (patient left)kidney 135 and aright kidney 134 together with leftrenal artery 132 and rightrenal artery 131. Any of the catheter devices shown and described herein can be inserted into the vascular anatomy via, for example, femoral access and thedistal portion 137 of the catheter is shown disposed within rightrenal artery 131. Ablation pulses are applied at such a location or at a multiplicity of similar locations in the renal artery to destroy renal nerve endings in the vessel wall of the renal artery. - A catheter assembly according to an embodiment is illustrated in
FIG. 2 in schematic form showing an expanded member (for purposes of non-limiting example, one form of the expanded member can be an inflated catheter balloon) on a catheter shaft with electrodes disposed on the shaft near the ends of the balloon. As shown inFIG. 2 , the distal portion of thecatheter 346 has aninflatable balloon 348 disposed betweenproximal electrode 350 anddistal electrode 351 located on either side (forward or backward along the device longitudinal axis) of the balloon. The electrodes are disposed with conducting surfaces exposed to the blood flow. Thus, the electrodes could be, for example, in the form of ring electrodes mounted on the catheter shaft and attached by an etching and gluing process, or swaged or crimped in place, or otherwise mounted by any of a range of processes known to those skilled in the art. Furthermore, an internal lumen for blood flow is present in the device between internallumen end sections openings electrode 350 andelectrode 351 so that blood flowing in the renal vessel can flow into the catheter internal lumen at one opening and out of the internal catheter lumen back into the renal vessel at the other opening, thus providing a shunt path for blood flow even when the balloon is inflated and is occluding most of the vessel cross section. As will be described in detail below, the blood path also offers advantages in terms of distribution of electric field when a voltage difference is applied between the electrodes for pulsed high voltage delivery. In a preferred embodiment, the distal tip of the catheter can be rounded gently or tapered and rounded so as to present a smooth, blunt distal tip profile. - A
catheter device 400 according to an embodiment is shown in a more detailed illustration (not to scale) inFIG. 3 . The distal portion of thecatheter shaft 401 has aninner lumen 403 that runs from the proximal catheter end (not shown) to the distal portion, for delivery of pressurized air or fluid (such as, for example, saline) that may be utilized to inflate the balloon. In the FIG., thelumen 403 starts from a cut plane or section AI and runs up to approximately the proximal end of the balloon (denoted by section C1), where it expands to fill a larger eccentric annular space within the catheter with openings (indicated by the small dotted ellipses such as 415 and 416) on the shaft that open into the balloon. Pressurized air or fluid injected into the proximal end of thelumen 403 can thus inflate theballoon 348 inFIG. 3 . Further, the catheter has a shorterinner lumen 409 providing a blood path, with ends indicated by thereference characters distal openings FIG. 1 ) can enter at one opening (for example, 353), flow inside theinner lumen 409 and exit through the other opening (for example, 354). - As shown, electrodes in the form of
rings balloon 348. Theelectrodes range 1 mm-6 mm, and a diameter in the range of about 1 mm to about 6 mm. The nearest edge-to-edge separation between electrodes can be in the range from about 3 mm to about 25 mm. - In one method of assembly, segmental pieces AI-B1, B1-C1, CI-D1, and DI-E1 with distinct and suitably mating lumen structures can comprise polymeric material, be extruded separately and joined by processes such as heat bonding that are well known to those skilled in the art. Various polymeric materials can be used in the construction; for example, the balloon can be made of thin polyurethane with suitable stretchability (or compliance) for inflation. The catheter shaft can comprise polymers such as Teflon, polyurethane, Nylon, PEEK (Poly Ester Ester Ketone) or polyethylene that are utilized frequently in the medical device industry and known to one skilled in the art. The balloon 348 (and any of the balloons or expanded members described herein) can have a length in the range 3 mm-25 mm and an inflated diameter in the
range 2 mm-6 mm. It is to be noted that in alternate embodiments, the inflatable balloon 348 (and any of the balloons or expanded members described herein) can instead be in the form of an expandable member, whether in the form of an expanded structure with a mesh-based unfolding structure, or a variety of other forms known to those skilled in the art. In the latter case the expandable member can have an expanded diameter in the range of about 2 mm to about 6 mm and a length in the range 3 mm-25 mm. - The catheter shaft can also include metallic mesh or braid constructions in the wall for torque transmission and suitable rigidity. The electrodes can include metals such as Platinum Iridium alloy, stainless steel, silver or other biocompatible metals that are known in the medical device industry as suitable electrode materials, and may be affixed to the catheter by an etching and gluing process, swaging, crimping or other processes known to one skilled in the art. The electrodes have leads attached to the inner or non-exposed side that run back to the catheter handle for connection to an appropriate electrical connector (not shown in
FIG. 3 ). The diameter of the catheter can be in the approximate range 0.8 mm-4 mm. While the materials and methods mentioned here are for illustrative purposes, it should be appreciated that those skilled in the art can conceive of the use of a variety of other materials and construction methods. - A schematic cutaway view of a
catheter 13 according to an embodiment is shown inFIG. 4 in a central longitudinal plane of the catheter with the plane passing through the longitudinal axis of the catheter, and showing the distal portion of the catheter with inflated balloon inside a blood vessel with a vessel wall and a blood pool in the annular space between the catheter and the vessel wall, together with blood path through the catheter. The distal portion of thecatheter 13 has aballoon 11 disposed on it, said balloon being inflated within a renal vessel with a thinvascular wall 12. The balloon includes an electrical insulator, for example in the form of a mechanically compliant polymer such as polyurethane.Electrodes 15 on either end of the balloon can be polarized with an electrical voltage or potential difference. Flowingblood pool 19 is present in the renal vessel, enters the inner catheter lumen throughopening 14 in the catheter wall and exits the inner lumen throughopening 141. In use, either of theelectrodes 15 can serve as anode, with the other member of the pair then taking on the role of cathode. Electrical leads (not shown) passing through a hollow lumen in the catheter connect to the respective electrodes for voltage delivery. The electrical leads are provided with suitable high dielectric strength insulation utilizing a suitable material such as for example Teflon. In some embodiments, the material and thickness of the high dielectric strength insulation is chosen so that it can withstand a voltage of at least 500 Volts in the electrical conductor of the lead without dielectric discharge or breakdown. As described herein, finite element analysis of the current density for the entire geometric region shown inFIG. 4 was conducted. In particular, the geometry shown can be used in a computational model with appropriate physical parameters (such as electrical conductivities) assigned to blood, tissue, metal and insulator to compute the electric potential and field in the spatial region around the catheter when a voltage or potential difference is applied between the electrodes. - Such a simulation result is shown in
FIG. 5 in the form of a shaded intensity plot for the electric potential, when theproximal electrode 15 has a high potential (500 Volts) and thedistal electrode 151 is assigned a low potential (ground or zero voltage).FIG. 5 also indicates thecatheter shaft 13,openings balloon 11 and thevessel wall 10. The electric potential is directly solved for in the computational model, and its negative gradient (the electric field vector E) may be thence evaluated as well as the current density j=o−E. The indicatedcontours FIG. 5 ) represent isopotential lines at approximate voltages of 500 Volts, 420 Volts, 320 Volts, and 250 Volts, respectively, while the dashedlines - A finite element analysis-derived spatial quiver plot of current density within a finite element geometry similar to that of
FIG. 4 but without a blood path through the catheter is depicted inFIG. 6 . The arrows in the quiver plot indicate the local direction of the current density vector and the arrow length indicates the magnitude of local current density when a defined electric potential difference is applied between the electrodes of the catheter, withelectrode 15 at a high potential andelectrode 151 at a low potential. The catheter shaft is indicated as 13 and thevessel wall 12 is also labeled in the FIG. along with theballoon 11. The current density exitselectrode 15 and enterselectrode 151 with the potential difference applied between the electrodes. It can be noted that there is a significant magnitude ofcurrent density 17 at or near the vessel wall, determined from the simulation to correspond to an electric field intensity or magnitude of over 1260 Volts/cm. - In like manner,
FIG. 7 depicts a finite element analysis-derived spatial quiver plot of current density within the finite element geometry ofFIG. 4 including a blood path through the catheter, again with the arrows in the quiver plot indicating the local direction of the current density vector and the arrow length indicating magnitude of local current density when a defined electric potential difference is applied between the electrodes of the catheter, withelectrode 15 at a high potential andelectrode 151 at a low potential. The catheter shaft is indicated as 13 and thevessel wall 12 is also labeled in the FIG. along with theballoon 11. The current density exitselectrode 15 and enterselectrode 151 with the potential difference applied between the electrodes. It can be noted that the magnitude ofcurrent density 23 at or near the vessel wall is now very small. Further, there is a significantcurrent density 21 near theopening 14 flowing in the same direction as the blood flow/path and exiting at theopening 141 before it loops back to enter atelectrode 151. In effect, excess current at the vessel wall has been shunted to flow through the blood path in the internal lumen of the catheter instead. Indeed, from the simulation it was determined that a peak electric field intensity or magnitude of approximately 500 Volts/cm was produced at the vessel wall. This electric field intensity is large enough to generate irreversible electroporation ablation while not being large enough to cause a local hot spot or thermal damage, in contrast to the case of the catheter device without the blood path. -
FIG. 8 illustrates a finite element analysis-derived spatial intensity plot of electric field within a three dimensional geometry including a catheter according to an embodiment with an inflated balloon and a blood path, the catheter placed within a blood vessel with a vessel wall and a blood pool in the annular space between the catheter and the vessel wall (i.e., the same configuration as is shown inFIG. 7 ).FIG. 8 shows a shaded intensity plot when a defined electric potential difference is applied between the electrodes of the catheter, withelectrode 15 at a high potential andelectrode 151 at a low potential. The catheter shaft is indicated as 13 and thevessel wall 12 is also labeled inFIG. 8 along with theballoon 11. The shaded area represents the region where the electric field intensity is approximately 500 V/cm, suitable for the irreversible electroporation of renal nerve endings in the vessel wall, and it can be seen as indicated by 41 that the vessel wall has an appropriate electric field intensity for ablation. - Regions with very high intensity electric fields (leading to thermal hot spots) have been effectively moved away from the interior of the vessel wall. In contrast, as mentioned in the foregoing, a similar catheter device without a blood path generates electric field intensities of over 1260 Volts/cm at the vessel wall.
- The sharp drop-off of electric field intensity from a localized peak along a longitudinal direction can be illustrated with line plots as for example shown in
FIGS. 9A and 9B .FIG. 9A shows a portion of the balloon catheter withballoon 11 andelectrode 151 disposed in a vessel witharterial walls 12. Alongitudinal line 145 oflength 1 cm centered at the point ofcontact 144 of the balloon with the wall (and with theline 145 disposed at the inner surface of the vessel wall) is used as a line along which electric field intensity is plotted inFIG. 9B . As seen inFIG. 9B , thepeak value 146 of electric field intensity along theline 145 ofFIG. 9A substantially drops from a value of approximately 1200 V/cm to avalue 147 of 500 V/cm within about 1 mm. - In one embodiment, the catheter has at least one anode-cathode pair of electrodes that are recessed from the exterior surface of the distal region of the catheter. With the electrodes positioned away in a radially inward manner from the diameter profile of the cross section of the catheter, the electric field generated due to an applied potential difference between the electrodes is not excessively large at the arterial wall, thus preserving the wall itself. At the same time, the nerve cells in the nerves present in the vascular wall are in the presence of an electric field large enough to generate irreversible electroporation and subsequent cell necrosis.
- The recessed electrodes contact blood in the vessel, with blood thus forming a portion of the electrical path between anode and cathode electrodes. The vascular wall also forms a portion of the electrical path between anode and cathode electrodes. In some embodiments, all the electrodes on the catheter are recessed so that there is no direct physical contact between any of the electrodes and the vascular wall. Thus, the intense electric field near the electrode surface is removed from the wall, reducing or eliminating the likelihood of vessel wall perforation while the electric field is still large enough to generate irreversible electroporation of the renal nerve endings therein. In some embodiments, a pair of anode and cathode electrodes are set in a recessed void in the catheter, and separated from each other by an insulator. The voltage pulses can for exemplary purposes have pulse widths in the range of tens to hundreds of microseconds. In some embodiments there could be a multiplicity of such voltage pulses applied through the electrodes, with an interval between pulses that can for illustrative purposes be in the range of tens to hundreds of microseconds. The generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or multiphasic forms and with either constant or progressively changing amplitudes.
- A catheter according to an embodiment having a recessed void in the exterior surface of the catheter, wherein recessed electrodes are disposed therein for applying electrical voltages for ablation purposes, is shown in
FIG. 10 . As shown, thedistal portion 511 of the catheter body has a recessedvoid 512 where electrodes are located, with anode and cathode electrodes on diametrically opposite sides of the catheter's central longitudinal axis. In some embodiments, the distal tip of the catheter can be rounded gently or tapered and rounded (not shown inFIG. 10 ) so as to present a smooth, blunt distal tip profile. - The internal arrangement of the electrodes within the recess is displayed more clearly in
FIG. 11 , which shows a schematic cross-sectional view of acatheter 511 in a central longitudinal plane of the catheter with the plane passing through the longitudinal axis of the catheter. As shown, thecatheter body 511 has a recess or void 512, within which are located metallic or electrically conductingelectrodes 21 disposed on either side of anelectrical insulator 522. The catheter body can be made of Teflon, polyurethane, Nylon, PEEK (Polyether Ether Ketone), polyethylene or any of a range of polymers commonly used in the medical device industry to build catheter devices and known to those skilled in the art. The diameter of the catheter can be in the approximate range 0.8 mm-4 mm. The void or recess can have a length dimension in the range 0.5 mm-5 mm and a width dimension in the range 0.2 mm-2 mm at the exterior catheter surface, while having a recess or depth dimension in the approximate range 0.5 mm-1.5 mm measured radially inward from the surface. The ratio of recess depth to catheter diameter can be in the range 0.1 to 0.45. The metallic electrodes can comprise biocompatible materials such as platinum iridium, stainless steel, silver or a range of other conductors familiar to one skilled in the art. The void can be fabricated by machining, drilling, punching or molding. The insulator between the electrodes can comprise materials such as Teflon or polyurethane that are known to have a high dielectric strength. The electrodes and insulator between the electrodes can be positioned by etching the catheter and held in place by a suitable gluing process. - It is to be noted that while
FIG. 11 shows a rectangular geometry for the electrodes and flat surfaces for the recess walls, more general shapes could be used in other embodiments. Thus for example ellipsoidal electrodes disposed in a recess with either flat or curved walls, approximately spherical or ellipsoidal recess walls, and so on can be used in some embodiments. In one embodiment, approximately rectangular parallelepiped electrodes are disposed in the catheter, with edges and corners rounded to result in gently curving forms in order to reduce or eliminate areas of high curvature, which can result in further reductions in electric field intensity distributions. -
FIG. 12 illustrates a schematic cutaway view of a catheter according to an embodiment along a central longitudinal plane of the catheter with the plane passing through the longitudinal axis of the catheter, and showing the catheter inside a blood vessel with avessel wall 531 and ablood pool 532 disposed in the annular space between the catheter and the vessel wall, together providing a geometry for finite element analysis. The recess or void 512 in the catheter body, and theelectrically conducting electrodes 521 within the void are indicated along with theelectrical insulator 522 disposed between theelectrodes 521. In use, either of theelectrodes 521 can serve as anode, with the other member of the pair then taking on the role of cathode. Electrical leads (not shown) passing through a hollow lumen in the catheter connect to the respective electrodes for voltage delivery. The electrical leads are provided with suitable high dielectric strength insulation utilizing a suitable material such as for example Teflon; the material and thickness of the high dielectric strength insulation is chosen so that it can withstand a voltage of at least 500 Volts in the electrical conductor of the lead without dielectric discharge or breakdown. In an alternate embodiment, the high dielectric strength insulation is chosen so that it can withstand a voltage of at least 2000 Volts in the electrical conductor of the lead without dielectric discharge or breakdown. - The three dimensional geometry of the catheter with the recessed electrodes within a blood vessel filled with blood is further illustrated in
FIG. 13 , where the inner cylinder represents thecatheter shaft 511 within a blood vessel illustrated byvessel wall 531 and withblood 532 disposed in the annular space between the catheter shaft and the vessel wall. Theelectrodes 512 andinsulator 522 between the electrodes are indicated within the catheter body. This geometry can be used in a computational model with appropriate physical parameters (such as electrical conductivities) assigned to blood, tissue, metal and insulator to compute the electric potential and field in the spatial region around the catheter when a voltage or potential difference is applied between the electrodes. - Such a simulation result is shown in
FIG. 14 in a longitudinal section view in the form of a contour plot for the electric potential, when thetop electrode 521 in the FIG. is assigned a high potential and the bottom electrode is assigned a low potential. In this example the high and low potentials were set at 500 Volts and zero respectively. The electric potential was directly solved for in the computational model, and its negative gradient (the electric field vector) was evaluated. InFIG. 14 ,contours FIG. 15 in a longitudinal section view, also in the form of a contour plot. This plot shows electricfield intensity contours regions 531 in the arterial vessel wall, theelectric field intensity 563 is significantly lower (approximately 500 Volts/cm). Thus, the very high electric field regions have been effectively moved away from the vessel wall. The electric field distribution with the same potential difference of 500 Volts between the electrodes is further clarified inFIG. 16 , which provides a line plot of electric field intensity along a line perpendicular to the catheter's longitudinal axis and along one of the transverse edges of the electrodes. The plot therein shows the line plot alongline 620, with the top portion of the FIG. (above the peaks in the plot) representing a rotated version of a portion of the contour plot ofFIG. 15 . Thuselectrodes 521 are visible along with arterial wall 531 (now running in the vertical direction in the top portion ofFIG. 16 ). Locally very high electric field intensity regions near internal corners of the electrodes are marked as contour 571 (corresponding to an electric field magnitude of approximately 14,000 Volts/cm).Contours line 620 from left to right in the FIG., the graphical plot in the lower portion ofFIG. 16 shows that theelectric field intensities peak value 625 that occurs near inner corners of the electrode. In particular, the electric field in the tissue wall of the vessel is large enough to generate irreversible electroporation therein without being large enough to cause a thermal hot spot. - An embodiment of the catheter device according to an embodiment with two pairs of anode-cathode ablation electrodes in the distal portion of the device is illustrated in
FIG. 17 , which shows thedistal portion 746 of the catheter device within arenal artery 745. While two pairs or sets of electrodes are shown in this illustration, in other embodiments, any number of electrodes can be disposed in the device without limitation.FIG. 17 shows a distal electrode set 748 withelectrodes insulating region 755. Also shown is aproximal electrode set 749. Electrical leads 758 and 759 connect toelectrodes electrical leads electrode set 749. The electrical leads are provided with suitable high dielectric strength insulation utilizing a suitable material such as for example Teflon; the material and thickness of the high dielectric strength insulation is chosen so that it can withstand a voltage of at least 500 Volts in the electrical conductor of the lead without dielectric discharge or breakdown. In an alternate embodiment the high dielectric strength insulation is chosen so that it can withstand a voltage of at least 2000 Volts in the electrical conductor of the lead without dielectric discharge or breakdown. - A schematic representation of an irreversible electroporation system is depicted in
FIG. 18 , and together with the catheter device disclosed herein it provides a complete therapeutic system for renal denervation ablation. A DC voltage/signal generator 73 is driven or triggered by acontroller unit 71 that interfaces with acomputer device 74 by means of a two-way communication link 79. The controller can perform channel selection and routing functions for applying DC voltages to appropriate electrodes that have been selected by a user or by thecomputer 74, and apply the voltages via a multiplicity of leads (shown collectively as 80) to acatheter device 72. In one embodiment the controller can also record and display impedance data from at least a pair of the electrodes of thecatheter device 72. Such impedance data could for instance be used to determine suitable arterial locations for ablation. While theDC voltage generator 73 sends a DC voltage to thecontroller 71 through high voltage leads 77, the voltage generator is triggered by control and timinginputs 78 from thecontroller unit 71. In one preferred embodiment thecomputer 74 is integrated with thecontroller 71 in a single enclosure. A user interface for the system can comprise multiple elements such as, for non-limiting purposes, a graphical display, a push button, foot pedal or joystick for user-triggered ablation application, a touch screen interface, or any of a variety of such interfaces that are familiar to those skilled in the art and as may be convenient for implementation and for user interaction in the context of the medical application. - A DC voltage for electroporation can be applied to the catheter electrodes. The DC voltage is applied in brief pulses sufficient to cause irreversible electroporation can be in the range of 0.5 kV to 10 kV and more preferably in the
range 1 kV to 4 kV, so that an appropriate threshold electric field is effectively achieved in the renal nerve tissue to be ablated. In one embodiment of the invention, the electrodes marked for ablation can be automatically identified, or manually identified by suitable marking, on an X-ray or fluoroscopic image obtained at an appropriate angulation that permits identification of the geometric distance between anode and cathode electrodes, or their respective centroids. In one embodiment, the DC voltage generator setting for irreversible electroporation is then automatically identified by the electroporation system based on this distance measure. In an alternate embodiment, the DC voltage value is selected directly by a user from a suitable dial, slider, touch screen, or any other user interface. The DC voltage pulse results in a current flowing between the anode and cathode electrodes, with said current flowing through the blood in the renal artery, the blood path through the catheter lumen, and the vessel wall tissue, with the current flowing from the anode and returning back through the cathode electrode. The forward and return current paths (leads) are both inside the catheter. - The controller and generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic or more generally, multiphasic forms and with either constant or progressively changing amplitudes.
FIG. 19 shows a rectangular wave pulse train where thepulses 101 have a uniform height or maximum voltage.FIG. 20 shows an example of a balanced biphasic rectangular pulse train, where each positive voltage pulse such as 103 is immediately followed by a negative voltage pulse such as 104 of equal amplitude and opposite sign. While in this example the biphasic pulses are balanced with equal amplitudes of the positive and negative voltages, in other embodiments an unbalanced biphasic waveform could also be used as may be convenient for a given application. - Yet another example of a waveform or pulse shape that can be generated by the system is illustrated in
FIG. 21 , which shows a progressive balanced rectangular pulse train, where each distinct biphasic pulse has equal-amplitude positive and negative voltages, but each pulse such as 107 is larger in amplitude than itsimmediate predecessor 106. Other variations such as a progressive unbalanced rectangular pulse train, or indeed a wide variety of other variations of pulse amplitude with respect to time can be conceived and implemented by those skilled in the art based on the teachings herein. - The time duration of each irreversible electroporation rectangular voltage pulse could lie in the range from 1 nanosecond to 10 milliseconds, with the
range 10 microseconds to 1 millisecond being more preferable and the range 50 microseconds to 300 microseconds being still more preferable. The time interval between successive pulses of a pulse train could be in the range of 1 nanosecond to 1 millisecond, with the range 50 microseconds to 300 microseconds being more preferable. The number of pulses applied in a single pulse train (with delays between individual pulses lying in the ranges just mentioned) can range from 1 to 100, with therange 1 to 10 being more preferable. In one embodiment, a pulse train can be driven by a user-controlled switch or button, in one embodiment mounted on a hand-held joystick-like device while in an alternate embodiment it could be in the form of a foot pedal and in still another embodiment it could be implemented with a computer mouse. Indeed a variety of such triggering schemes can be implemented by those skilled in the art, as convenient for the application and without departing from the scope of the present invention. In one mode of operation a pulse train can be generated for every push of such a control button, while in an alternate mode of operation pulse trains can be generated repeatedly for as long as the user-controlled switch or button is engaged by the user. - While several specific examples and embodiments of systems and tools for tissue ablation with irreversible electroporation were described in the foregoing for illustrative and purposes, it should be clear that a wide variety of variations and alternate embodiments could be conceived or constructed by those skilled in the art based on the teachings of the present invention. Persons skilled in the art would recognize that any of a wide variety of other control or user input methods and device variations can be implemented without departing from the scope of the embodiments described herein. Likewise, while the foregoing described specific tools or devices for more effective and selective DC voltage application for irreversible electroporation, other device constructions and variations could be implemented by one skilled in the art by employing the principles and teachings disclosed herein without departing from the scope of the present invention. For example, while the description above discussed one electrode located proximal to the balloon and another electrode located distal to the balloon, in one variation a multiplicity of electrodes could be located proximal to the balloon and a multiplicity of electrodes could be located distal to the balloon.
- Although various embodiments have been described as having particular features and/or combinations of components, other embodiments are possible having a combination of any features and/or components from any of embodiments as discussed above. For example, in some embodiments, a device can include an expandable member similar to the expanded member shown and described with reference to
FIGS. 2 and 3 along with a recessed electrode similar to the recessed electrodes shown and described with reference toFIGS. 11 through 13 .
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/170,348 US20230190368A1 (en) | 2014-01-06 | 2023-02-16 | Apparatus and methods for renal denervation ablation |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461923969P | 2014-01-06 | 2014-01-06 | |
US201461923966P | 2014-01-06 | 2014-01-06 | |
PCT/US2015/010223 WO2015103574A1 (en) | 2014-01-06 | 2015-01-06 | Apparatus and methods for renal denervation ablation |
US15/201,997 US10517672B2 (en) | 2014-01-06 | 2016-07-05 | Apparatus and methods for renal denervation ablation |
US16/719,708 US11589919B2 (en) | 2014-01-06 | 2019-12-18 | Apparatus and methods for renal denervation ablation |
US18/170,348 US20230190368A1 (en) | 2014-01-06 | 2023-02-16 | Apparatus and methods for renal denervation ablation |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/719,708 Continuation US11589919B2 (en) | 2014-01-06 | 2019-12-18 | Apparatus and methods for renal denervation ablation |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230190368A1 true US20230190368A1 (en) | 2023-06-22 |
Family
ID=53494110
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/201,997 Active US10517672B2 (en) | 2014-01-06 | 2016-07-05 | Apparatus and methods for renal denervation ablation |
US16/719,708 Active 2036-03-01 US11589919B2 (en) | 2014-01-06 | 2019-12-18 | Apparatus and methods for renal denervation ablation |
US18/170,348 Pending US20230190368A1 (en) | 2014-01-06 | 2023-02-16 | Apparatus and methods for renal denervation ablation |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/201,997 Active US10517672B2 (en) | 2014-01-06 | 2016-07-05 | Apparatus and methods for renal denervation ablation |
US16/719,708 Active 2036-03-01 US11589919B2 (en) | 2014-01-06 | 2019-12-18 | Apparatus and methods for renal denervation ablation |
Country Status (3)
Country | Link |
---|---|
US (3) | US10517672B2 (en) |
EP (1) | EP3091921B1 (en) |
WO (1) | WO2015103574A1 (en) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2882336B1 (en) | 2012-08-09 | 2019-06-26 | University of Iowa Research Foundation | Catheter systems for puncturing through a tissue structure |
EP3091921B1 (en) | 2014-01-06 | 2019-06-19 | Farapulse, Inc. | Apparatus for renal denervation ablation |
EP3495018B1 (en) | 2014-05-07 | 2023-09-06 | Farapulse, Inc. | Apparatus for selective tissue ablation |
EP3154464A4 (en) | 2014-06-12 | 2018-01-24 | Iowa Approach Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
EP3154463B1 (en) | 2014-06-12 | 2019-03-27 | Farapulse, Inc. | Apparatus for rapid and selective transurethral tissue ablation |
WO2016060983A1 (en) | 2014-10-14 | 2016-04-21 | Iowa Approach Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
CN107921258B (en) * | 2015-08-06 | 2021-09-07 | 美敦力公司 | Cardiac pulsed field ablation |
US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US20170189097A1 (en) | 2016-01-05 | 2017-07-06 | Iowa Approach Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10130423B1 (en) | 2017-07-06 | 2018-11-20 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
WO2017218734A1 (en) | 2016-06-16 | 2017-12-21 | Iowa Approach, Inc. | Systems, apparatuses, and methods for guide wire delivery |
CN114098949B (en) | 2016-06-27 | 2023-12-19 | 盖能适治疗股份有限公司 | Generator and catheter with electrode |
US9987081B1 (en) | 2017-04-27 | 2018-06-05 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
US10617867B2 (en) | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
CN111065327B (en) | 2017-09-12 | 2023-01-06 | 波士顿科学医学有限公司 | Systems, devices, and methods for ventricular focal ablation |
EP3694432B1 (en) * | 2017-10-13 | 2024-05-01 | Mayo Foundation for Medical Education and Research | Devices for electroporation for treatment of ventricular fibrillation |
US11541241B2 (en) | 2017-12-11 | 2023-01-03 | Mayo Foundation For Medical Education And Research | Methods and systems for electroporation |
US20190336198A1 (en) | 2018-05-03 | 2019-11-07 | Farapulse, Inc. | Systems, devices, and methods for ablation using surgical clamps |
WO2019217300A1 (en) | 2018-05-07 | 2019-11-14 | Farapulse, Inc. | Epicardial ablation catheter |
JP7379377B2 (en) | 2018-05-07 | 2023-11-14 | ファラパルス,インコーポレイテッド | Systems, devices, and methods for filtering high voltage noise induced by pulsed electric field ablation |
WO2019217433A1 (en) | 2018-05-07 | 2019-11-14 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
CN112955088A (en) | 2018-09-20 | 2021-06-11 | 法拉普尔赛股份有限公司 | Systems, devices, and methods for delivering pulsed electric field ablation energy to endocardial tissue |
US12102293B2 (en) * | 2019-08-30 | 2024-10-01 | Biosese Webster (Israel) Ltd. | ENT guidewire |
US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
US11707320B2 (en) * | 2019-12-24 | 2023-07-25 | Biosense Webster (Israel) Ltd. | Irreversible electroporation (IRE) based on field, contact force and time |
US12076071B2 (en) | 2020-08-14 | 2024-09-03 | Kardium Inc. | Systems and methods for treating tissue with pulsed field ablation |
WO2022145554A1 (en) * | 2021-01-04 | 2022-07-07 | 재단법인 아산사회복지재단 | Electrode stent locoregional thermal therapy device using bipolar electrode |
AU2022254861B2 (en) | 2021-04-07 | 2024-01-18 | Btl Medical Development A.S. | Pulsed field ablation device and method |
IL309432B1 (en) | 2021-07-06 | 2024-10-01 | Btl Medical Dev A S | Pulsed field ablation device and method |
WO2024075034A1 (en) | 2022-10-05 | 2024-04-11 | Btl Medical Technologies S.R.O. | Pulsed field ablation device and method |
EP4445855A1 (en) * | 2023-04-13 | 2024-10-16 | BIOTRONIK SE & Co. KG | Method and catheter for renal denervation |
Family Cites Families (526)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4200104A (en) | 1977-11-17 | 1980-04-29 | Valleylab, Inc. | Contact area measurement apparatus for use in electrosurgery |
US4470407A (en) * | 1982-03-11 | 1984-09-11 | Laserscope, Inc. | Endoscopic device |
US5547467A (en) | 1988-01-21 | 1996-08-20 | Massachusettes Institute Of Technology | Method for rapid temporal control of molecular transport across tissue |
US5344435A (en) | 1988-07-28 | 1994-09-06 | Bsd Medical Corporation | Urethral inserted applicator prostate hyperthermia |
US5257635A (en) | 1988-11-25 | 1993-11-02 | Sensor Electronics, Inc. | Electrical heating catheter |
US5749914A (en) * | 1989-01-06 | 1998-05-12 | Advanced Coronary Intervention | Catheter for obstructed stent |
US5342301A (en) * | 1992-08-13 | 1994-08-30 | Advanced Polymers Incorporated | Multi-lumen balloons and catheters made therewith |
WO1992021285A1 (en) | 1991-05-24 | 1992-12-10 | Ep Technologies, Inc. | Combination monophasic action potential/ablation catheter and high-performance filter system |
US6029671A (en) | 1991-07-16 | 2000-02-29 | Heartport, Inc. | System and methods for performing endovascular procedures |
US5524338A (en) * | 1991-10-22 | 1996-06-11 | Pi Medical Corporation | Method of making implantable microelectrode |
US5242441A (en) | 1992-02-24 | 1993-09-07 | Boaz Avitall | Deflectable catheter with rotatable tip electrode |
US5281213A (en) | 1992-04-16 | 1994-01-25 | Implemed, Inc. | Catheter for ice mapping and ablation |
US5443463A (en) | 1992-05-01 | 1995-08-22 | Vesta Medical, Inc. | Coagulating forceps |
US5341807A (en) | 1992-06-30 | 1994-08-30 | American Cardiac Ablation Co., Inc. | Ablation catheter positioning system |
US5700243A (en) * | 1992-10-30 | 1997-12-23 | Pdt Systems, Inc. | Balloon perfusion catheter |
US6068653A (en) | 1992-11-13 | 2000-05-30 | Scimed Life Systems, Inc. | Electrophysiology catheter device |
US5334193A (en) | 1992-11-13 | 1994-08-02 | American Cardiac Ablation Co., Inc. | Fluid cooled ablation catheter |
US5545161A (en) * | 1992-12-01 | 1996-08-13 | Cardiac Pathways Corporation | Catheter for RF ablation having cooled electrode with electrically insulated sleeve |
US6749604B1 (en) | 1993-05-10 | 2004-06-15 | Arthrocare Corporation | Electrosurgical instrument with axially-spaced electrodes |
US5531685A (en) | 1993-06-11 | 1996-07-02 | Catheter Research, Inc. | Steerable variable stiffness device |
FR2708860B1 (en) | 1993-08-11 | 1995-10-13 | Ela Medical Sa | Protection circuit for implantable electronic device. |
US5545193A (en) | 1993-10-15 | 1996-08-13 | Ep Technologies, Inc. | Helically wound radio-frequency emitting electrodes for creating lesions in body tissue |
US5722400A (en) | 1995-02-16 | 1998-03-03 | Daig Corporation | Guiding introducers for use in the treatment of left ventricular tachycardia |
US5921924A (en) | 1993-12-03 | 1999-07-13 | Avitall; Boaz | Mapping and ablation catheter system utilizing multiple control elements |
US5454370A (en) | 1993-12-03 | 1995-10-03 | Avitall; Boaz | Mapping and ablation electrode configuration |
US5928269A (en) | 1994-04-04 | 1999-07-27 | Alt; Eckhard | Apparatus and method for temporary atrial defibrillation with external defibrillator and implanted transvenous catheter and electrodes |
US5578040A (en) | 1994-06-14 | 1996-11-26 | Smith; Albert C. | Ocular repair system and apparatus |
US5617854A (en) | 1994-06-22 | 1997-04-08 | Munsif; Anand | Shaped catheter device and method |
US6071274A (en) | 1996-12-19 | 2000-06-06 | Ep Technologies, Inc. | Loop structures for supporting multiple electrode elements |
US5836947A (en) | 1994-10-07 | 1998-11-17 | Ep Technologies, Inc. | Flexible structures having movable splines for supporting electrode elements |
US5876336A (en) | 1994-10-11 | 1999-03-02 | Ep Technologies, Inc. | Systems and methods for guiding movable electrode elements within multiple-electrode structure |
US5722402A (en) | 1994-10-11 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods for guiding movable electrode elements within multiple-electrode structures |
US5624430A (en) | 1994-11-28 | 1997-04-29 | Eton; Darwin | Magnetic device to assist transcorporeal guidewire placement |
US5810762A (en) | 1995-04-10 | 1998-09-22 | Genetronics, Inc. | Electroporation system with voltage control feedback for clinical applications |
US6090104A (en) | 1995-06-07 | 2000-07-18 | Cordis Webster, Inc. | Catheter with a spirally wound flat ribbon electrode |
US20060024359A1 (en) | 1995-06-07 | 2006-02-02 | Walker Jeffrey P | Drug delivery system and method |
US5702438A (en) | 1995-06-08 | 1997-12-30 | Avitall; Boaz | Expandable recording and ablation catheter system |
US5788692A (en) | 1995-06-30 | 1998-08-04 | Fidus Medical Technology Corporation | Mapping ablation catheter |
US6023638A (en) | 1995-07-28 | 2000-02-08 | Scimed Life Systems, Inc. | System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue |
US5706823A (en) | 1995-08-18 | 1998-01-13 | Quinton Instrument Company | Electrophysiology filtering system |
DE69631681T2 (en) | 1995-10-06 | 2004-07-29 | Cordis Webster, Inc., Diamond Bar | ELECTRODE CATHETER WITH DIVIDED TIP |
DE29519651U1 (en) | 1995-12-14 | 1996-02-01 | Muntermann, Axel, 35583 Wetzlar | Device for linear radio frequency catheter ablation of endomyocardial tissue |
BR9612395A (en) | 1995-12-29 | 1999-07-13 | Gyrus Medical Ltd | Electrosurgical instrument and an electrosurgical electrode set |
US7141049B2 (en) | 1999-03-09 | 2006-11-28 | Thermage, Inc. | Handpiece for treatment of tissue |
US5836874A (en) | 1996-04-08 | 1998-11-17 | Ep Technologies, Inc. | Multi-function electrode structures for electrically analyzing and heating body tissue |
WO1997025917A1 (en) | 1996-01-19 | 1997-07-24 | Ep Technologies, Inc. | Multi-function electrode structures for electrically analyzing and heating body tissue |
US5868736A (en) | 1996-04-12 | 1999-02-09 | Ep Technologies, Inc. | Systems and methods to control tissue heating or ablation with porous electrode structures |
US5800482A (en) | 1996-03-06 | 1998-09-01 | Cardiac Pathways Corporation | Apparatus and method for linear lesion ablation |
US5830224A (en) | 1996-03-15 | 1998-11-03 | Beth Israel Deaconess Medical Center | Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo |
US5779699A (en) | 1996-03-29 | 1998-07-14 | Medtronic, Inc. | Slip resistant field focusing ablation catheter electrode |
US5836942A (en) | 1996-04-04 | 1998-11-17 | Minnesota Mining And Manufacturing Company | Biomedical electrode with lossy dielectric properties |
US5863291A (en) | 1996-04-08 | 1999-01-26 | Cardima, Inc. | Linear ablation assembly |
US5904709A (en) * | 1996-04-17 | 1999-05-18 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Microwave treatment for cardiac arrhythmias |
US5672170A (en) | 1996-06-20 | 1997-09-30 | Cynosure, Inc. | Laser transmyocardial revascularization arrangement |
US6006131A (en) | 1996-08-13 | 1999-12-21 | Uab Research Foundation | Dual current pathway atrial defibrillation apparatus |
EP0832602B1 (en) | 1996-09-27 | 2004-03-17 | Sulzer Osypka GmbH | Device for carrying out diagnostic and/or therapeutic heart procedures with a catheter |
US6805128B1 (en) | 1996-10-22 | 2004-10-19 | Epicor Medical, Inc. | Apparatus and method for ablating tissue |
US6311692B1 (en) | 1996-10-22 | 2001-11-06 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US7052493B2 (en) | 1996-10-22 | 2006-05-30 | Epicor Medical, Inc. | Methods and devices for ablation |
US6096036A (en) | 1998-05-05 | 2000-08-01 | Cardiac Pacemakers, Inc. | Steerable catheter with preformed distal shape and method for use |
US6002955A (en) | 1996-11-08 | 1999-12-14 | Medtronic, Inc. | Stabilized electrophysiology catheter and method for use |
US5916213A (en) | 1997-02-04 | 1999-06-29 | Medtronic, Inc. | Systems and methods for tissue mapping and ablation |
US5899917A (en) * | 1997-03-12 | 1999-05-04 | Cardiosynopsis, Inc. | Method for forming a stent in situ |
US6223085B1 (en) * | 1997-05-06 | 2001-04-24 | Urologix, Inc. | Device and method for preventing restenosis |
US6012457A (en) | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US5849028A (en) | 1997-05-16 | 1998-12-15 | Irvine Biomedical, Inc. | Catheter and method for radiofrequency ablation of cardiac tissue |
US5978704A (en) | 1997-06-03 | 1999-11-02 | Uab Research Foundation | Method and apparatus for treating cardiac arrhythmia |
US5938660A (en) | 1997-06-27 | 1999-08-17 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
US6966908B2 (en) * | 1997-07-08 | 2005-11-22 | Atrionix, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
US6164283A (en) | 1997-07-08 | 2000-12-26 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
WO1999002096A1 (en) | 1997-07-08 | 1999-01-21 | The Regents Of The University Of California | Circumferential ablation device assembly and method |
US6245064B1 (en) | 1997-07-08 | 2001-06-12 | Atrionix, Inc. | Circumferential ablation device assembly |
US6009351A (en) | 1997-07-14 | 1999-12-28 | Urologix, Inc. | System and method for transurethral heating with rectal cooling |
US6014579A (en) | 1997-07-21 | 2000-01-11 | Cardiac Pathways Corp. | Endocardial mapping catheter with movable electrode |
EP0932428A1 (en) | 1997-07-22 | 1999-08-04 | Emed Corporation | Iontophoretic delivery of an agent into cardiac tissue |
US6216034B1 (en) | 1997-08-01 | 2001-04-10 | Genetronics, Inc. | Method of programming an array of needle electrodes for electroporation therapy of tissue |
US5895404A (en) | 1997-09-29 | 1999-04-20 | Ruiz; Carlos E. | Apparatus and methods for percutaneously forming a passageway between adjacent vessels or portions of a vessel |
US6071281A (en) | 1998-05-05 | 2000-06-06 | Ep Technologies, Inc. | Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same |
US6645200B1 (en) | 1997-10-10 | 2003-11-11 | Scimed Life Systems, Inc. | Method and apparatus for positioning a diagnostic or therapeutic element within the body and tip electrode for use with same |
US6464699B1 (en) | 1997-10-10 | 2002-10-15 | Scimed Life Systems, Inc. | Method and apparatus for positioning a diagnostic or therapeutic element on body tissue and mask element for use with same |
WO1999022659A1 (en) | 1997-10-31 | 1999-05-14 | C.R. Bard, Inc. | Ring electrode structure for diagnostic and ablation catheters |
US6120500A (en) | 1997-11-12 | 2000-09-19 | Daig Corporation | Rail catheter ablation and mapping system |
US5928270A (en) | 1997-12-02 | 1999-07-27 | Cardiocommand, Inc. | Method and apparatus for incremental cardioversion or defibrillation |
US6447505B2 (en) | 1998-02-11 | 2002-09-10 | Cosman Company, Inc. | Balloon catheter method for intra-urethral radio-frequency urethral enlargement |
US6517534B1 (en) | 1998-02-11 | 2003-02-11 | Cosman Company, Inc. | Peri-urethral ablation |
US6167291A (en) | 1998-03-12 | 2000-12-26 | Cardima, Inc. | Protected pin connector for an electrophysiology catheter |
DE19817553A1 (en) | 1998-04-15 | 1999-10-21 | Biotronik Mess & Therapieg | Ablation arrangement |
US6146381A (en) | 1998-05-05 | 2000-11-14 | Cardiac Pacemakers, Inc. | Catheter having distal region for deflecting axial forces |
US6592581B2 (en) | 1998-05-05 | 2003-07-15 | Cardiac Pacemakers, Inc. | Preformed steerable catheter with movable outer sleeve and method for use |
US6045550A (en) | 1998-05-05 | 2000-04-04 | Cardiac Peacemakers, Inc. | Electrode having non-joined thermocouple for providing multiple temperature-sensitive junctions |
US6527767B2 (en) * | 1998-05-20 | 2003-03-04 | New England Medical Center | Cardiac ablation system and method for treatment of cardiac arrhythmias and transmyocardial revascularization |
US6231518B1 (en) | 1998-05-26 | 2001-05-15 | Comedicus Incorporated | Intrapericardial electrophysiological procedures |
US6287306B1 (en) | 1998-06-22 | 2001-09-11 | Daig Corporation | Even temperature linear lesion ablation catheter |
US6251107B1 (en) | 1998-06-25 | 2001-06-26 | Cardima, Inc. | Ep catheter |
US6322559B1 (en) | 1998-07-06 | 2001-11-27 | Vnus Medical Technologies, Inc. | Electrode catheter having coil structure |
US6623480B1 (en) | 1998-07-24 | 2003-09-23 | University Of Kentucky Research Foundation | Flexible recording/high energy electrode catheter with anchor for ablation of atrial flutter by radio frequency energy |
US7435247B2 (en) * | 1998-08-11 | 2008-10-14 | Arthrocare Corporation | Systems and methods for electrosurgical tissue treatment |
US6251128B1 (en) | 1998-09-01 | 2001-06-26 | Fidus Medical Technology Corporation | Microwave ablation catheter with loop configuration |
US8308719B2 (en) | 1998-09-21 | 2012-11-13 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Apparatus and method for ablating tissue |
US6807447B2 (en) | 1998-09-25 | 2004-10-19 | Ep Medsystems, Inc. | Triple array defibrillation catheter and method of using the same |
US6033403A (en) | 1998-10-08 | 2000-03-07 | Irvine Biomedical, Inc. | Long electrode catheter system and methods thereof |
US6638278B2 (en) | 1998-11-23 | 2003-10-28 | C. R. Bard, Inc. | Intracardiac grasp catheter |
IT1302900B1 (en) | 1998-12-04 | 2000-10-10 | Riccardo Fenici | AMAGNETIC CATHETER FOR THE SINGLE-CATHETER REGISTRATION OF MULTIPLE SINGLE-PHASE ACTION POTENTIALS, LOCABLE THREE-DIMENSIONALLY AND |
US20070066972A1 (en) * | 2001-11-29 | 2007-03-22 | Medwaves, Inc. | Ablation catheter apparatus with one or more electrodes |
US6219582B1 (en) | 1998-12-30 | 2001-04-17 | Daig Corporation | Temporary atrial cardioversion catheter |
US6206831B1 (en) | 1999-01-06 | 2001-03-27 | Scimed Life Systems, Inc. | Ultrasound-guided ablation catheter and methods of use |
US20010007070A1 (en) | 1999-04-05 | 2001-07-05 | Medtronic, Inc. | Ablation catheter assembly and method for isolating a pulmonary vein |
US6702811B2 (en) | 1999-04-05 | 2004-03-09 | Medtronic, Inc. | Ablation catheter assembly with radially decreasing helix and method of use |
US6270476B1 (en) | 1999-04-23 | 2001-08-07 | Cryocath Technologies, Inc. | Catheter |
US6272384B1 (en) | 1999-05-27 | 2001-08-07 | Urologix, Inc. | Microwave therapy apparatus |
US7171263B2 (en) | 1999-06-04 | 2007-01-30 | Impulse Dynamics Nv | Drug delivery device |
US6391024B1 (en) | 1999-06-17 | 2002-05-21 | Cardiac Pacemakers, Inc. | RF ablation apparatus and method having electrode/tissue contact assessment scheme and electrocardiogram filtering |
US6300108B1 (en) | 1999-07-21 | 2001-10-09 | The Regents Of The University Of California | Controlled electroporation and mass transfer across cell membranes |
DE19938558A1 (en) | 1999-08-17 | 2001-02-22 | Axel Muntermann | Catheters with improved electrical properties and treatment methods for improving the electrical properties of catheters |
US6607520B2 (en) | 1999-09-15 | 2003-08-19 | The General Hospital Corporation | Coiled ablation catheter system |
US6370412B1 (en) | 1999-10-07 | 2002-04-09 | Massachusetts Institute Of Technology | Method and apparatus for guiding ablative therapy of abnormal biological electrical excitation |
US6613062B1 (en) | 1999-10-29 | 2003-09-02 | Medtronic, Inc. | Method and apparatus for providing intra-pericardial access |
US6529756B1 (en) | 1999-11-22 | 2003-03-04 | Scimed Life Systems, Inc. | Apparatus for mapping and coagulating soft tissue in or around body orifices |
US6892091B1 (en) | 2000-02-18 | 2005-05-10 | Biosense, Inc. | Catheter, method and apparatus for generating an electrical map of a chamber of the heart |
DE10008918A1 (en) | 2000-02-25 | 2001-08-30 | Biotronik Mess & Therapieg | Ablation catheter to generate linear lesions in heart muscle; has catheter body with linear, cylindrical ablation electrode and at least one insulated sensing electrode |
US6743227B2 (en) | 2000-03-31 | 2004-06-01 | Medtronic, Inc. | Intraluminal visualization system with deflectable mechanism |
US7497844B2 (en) | 2000-03-31 | 2009-03-03 | Medtronic, Inc. | System and method for positioning implantable medical devices within coronary veins |
US6652517B1 (en) | 2000-04-25 | 2003-11-25 | Uab Research Foundation | Ablation catheter, system, and method of use thereof |
US20020107514A1 (en) | 2000-04-27 | 2002-08-08 | Hooven Michael D. | Transmural ablation device with parallel jaws |
US6546935B2 (en) | 2000-04-27 | 2003-04-15 | Atricure, Inc. | Method for transmural ablation |
US6932811B2 (en) | 2000-04-27 | 2005-08-23 | Atricure, Inc. | Transmural ablation device with integral EKG sensor |
US6743239B1 (en) | 2000-05-25 | 2004-06-01 | St. Jude Medical, Inc. | Devices with a bendable tip for medical procedures |
AU2001279026B2 (en) | 2000-07-25 | 2005-12-22 | Angiodynamics, Inc. | Apparatus for detecting and treating tumors using localized impedance measurement |
US8251986B2 (en) | 2000-08-17 | 2012-08-28 | Angiodynamics, Inc. | Method of destroying tissue cells by eletroporation |
US7081114B2 (en) | 2000-11-29 | 2006-07-25 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Electrophysiology/ablation catheter having lariat configuration of variable radius |
US6728563B2 (en) | 2000-11-29 | 2004-04-27 | St. Jude Medical, Daig Division, Inc. | Electrophysiology/ablation catheter having “halo” configuration |
AU2002248196A1 (en) | 2000-12-15 | 2002-08-12 | Tony R. Brown | Atrial fibrillation rf treatment device and method |
DE10102254A1 (en) | 2001-01-19 | 2002-08-08 | Celon Ag Medical Instruments | Device for the electrothermal treatment of the human or animal body |
US7229402B2 (en) | 2001-02-09 | 2007-06-12 | Cardiac Output Technologies, Inc. | Minimally invasive ventricular assist technology and method |
US7137975B2 (en) | 2001-02-13 | 2006-11-21 | Aciont, Inc. | Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent |
US6666862B2 (en) | 2001-03-01 | 2003-12-23 | Cardiac Pacemakers, Inc. | Radio frequency ablation system and method linking energy delivery with fluid flow |
US6666863B2 (en) | 2001-03-01 | 2003-12-23 | Scimed Life Systems, Inc. | Device and method for percutaneous myocardial revascularization |
US6743225B2 (en) | 2001-03-27 | 2004-06-01 | Uab Research Foundation | Electrophysiologic measure of endpoints for ablation lesions created in fibrillating substrates |
EP1383567B1 (en) | 2001-04-27 | 2007-11-28 | C.R. Bard, Inc. | Electrophysiology catheter for mapping and/or ablation |
US6972016B2 (en) | 2001-05-01 | 2005-12-06 | Cardima, Inc. | Helically shaped electrophysiology catheter |
US6771996B2 (en) | 2001-05-24 | 2004-08-03 | Cardiac Pacemakers, Inc. | Ablation and high-resolution mapping catheter system for pulmonary vein foci elimination |
US6685702B2 (en) | 2001-07-06 | 2004-02-03 | Rodolfo C. Quijano | Device for treating tissue and methods thereof |
US20030018374A1 (en) * | 2001-07-16 | 2003-01-23 | Paulos Lonnie E. | Treatment probe using RF energy |
US6994706B2 (en) | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
US7182725B2 (en) | 2001-09-24 | 2007-02-27 | Best Vascular, Inc. | Methods and apparatus employing ionizing radiation for treatment of cardiac arrhythmia |
JP4450622B2 (en) | 2001-09-28 | 2010-04-14 | アンジオ ダイナミクス インコーポレイテッド | Impedance-controlled tissue peeling device and method |
US7285116B2 (en) | 2004-05-15 | 2007-10-23 | Irvine Biomedical Inc. | Non-contact tissue ablation device and methods thereof |
US8175680B2 (en) | 2001-11-09 | 2012-05-08 | Boston Scientific Scimed, Inc. | Systems and methods for guiding catheters using registered images |
US6669693B2 (en) | 2001-11-13 | 2003-12-30 | Mayo Foundation For Medical Education And Research | Tissue ablation device and methods of using |
US7542807B2 (en) | 2001-12-04 | 2009-06-02 | Endoscopic Technologies, Inc. | Conduction block verification probe and method of use |
US6740084B2 (en) | 2001-12-18 | 2004-05-25 | Ethicon, Inc. | Method and device to enhance RF electrode performance |
US7493156B2 (en) | 2002-01-07 | 2009-02-17 | Cardiac Pacemakers, Inc. | Steerable guide catheter with pre-shaped rotatable shaft |
US8062251B2 (en) | 2002-02-01 | 2011-11-22 | Vascular Designs, Inc. | Multi-function catheter and use thereof |
US6926714B1 (en) | 2002-02-05 | 2005-08-09 | Jasbir S. Sra | Method for pulmonary vein isolation and catheter ablation of other structures in the left atrium in atrial fibrillation |
US6733499B2 (en) | 2002-02-28 | 2004-05-11 | Biosense Webster, Inc. | Catheter having circular ablation assembly |
US6869414B2 (en) | 2002-03-22 | 2005-03-22 | Cardiac Pacemakers, Inc. | Pre-shaped catheter with proximal articulation and pre-formed distal end |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US8774913B2 (en) * | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
US7617005B2 (en) * | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US6764486B2 (en) | 2002-04-24 | 2004-07-20 | Biotronik Mess- und Therapieger{haeck over (a)}te GmbH & Co. Ingenieurbüro Berlin | Ablation device for cardiac tissue, especially for forming a circular lesion around a vessel orifice in the heart |
DE10218427A1 (en) | 2002-04-24 | 2003-11-06 | Biotronik Mess & Therapieg | Ablation device for cardiac tissue, in particular for creating a circular lesion around a vascular mouth in the heart |
US20030204161A1 (en) | 2002-04-25 | 2003-10-30 | Bozidar Ferek-Petric | Implantable electroporation therapy device and method for using same |
US6780178B2 (en) | 2002-05-03 | 2004-08-24 | The Board Of Trustees Of The Leland Stanford Junior University | Method and apparatus for plasma-mediated thermo-electrical ablation |
AU2003239474A1 (en) | 2002-05-17 | 2003-12-02 | Stan F. Obino | Device and method for the treatment of cardiac disorders |
JP4338631B2 (en) | 2002-05-27 | 2009-10-07 | セロン アクチエンゲゼルシャフト メディカル インスツルメンツ | Device for hardening body tissue by electrosurgery (thermal scrosis) |
US20030229379A1 (en) | 2002-06-06 | 2003-12-11 | Maynard Ramsey | Method for cardioversion or defibrillation using electrical impulses at pacing strength |
US7367974B2 (en) | 2004-09-20 | 2008-05-06 | Wisconsin Alumni Research Foundation | Electrode array for tissue ablation |
US20040082859A1 (en) | 2002-07-01 | 2004-04-29 | Alan Schaer | Method and apparatus employing ultrasound energy to treat body sphincters |
US7258690B2 (en) * | 2003-03-28 | 2007-08-21 | Relievant Medsystems, Inc. | Windowed thermal ablation probe |
US7001383B2 (en) | 2002-10-21 | 2006-02-21 | Biosense, Inc. | Real-time monitoring and mapping of ablation lesion formation in the heart |
US20040082947A1 (en) | 2002-10-25 | 2004-04-29 | The Regents Of The University Of Michigan | Ablation catheters |
US9730100B2 (en) | 2002-10-28 | 2017-08-08 | MeshDynamics | Terse message networks |
US9819747B2 (en) | 2008-11-24 | 2017-11-14 | MeshDynamics | Chirp networks |
WO2004045672A2 (en) | 2002-11-15 | 2004-06-03 | The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services | Variable curve catheter |
EP1562506B1 (en) | 2002-11-15 | 2009-05-13 | C.R.Bard, Inc. | Electrophysiology catheter with ablation electrode |
US7195628B2 (en) | 2002-12-11 | 2007-03-27 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Atrial fibrillation therapy with pulmonary vein support |
US6984232B2 (en) | 2003-01-17 | 2006-01-10 | St. Jude Medical, Daig Division, Inc. | Ablation catheter assembly having a virtual electrode comprising portholes |
US6960207B2 (en) | 2003-01-21 | 2005-11-01 | St Jude Medical, Daig Division, Inc. | Ablation catheter having a virtual electrode comprising portholes and a porous conductor |
US8192425B2 (en) | 2006-09-29 | 2012-06-05 | Baylis Medical Company Inc. | Radiofrequency perforation apparatus |
US7387629B2 (en) | 2003-01-21 | 2008-06-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter design that facilitates positioning at tissue to be diagnosed or treated |
US7622172B2 (en) | 2003-02-19 | 2009-11-24 | Erick Keenan | Composite flexible and conductive catheter electrode |
US20070276361A1 (en) | 2003-03-28 | 2007-11-29 | Debbie Stevens-Wright | Method and apparatus for adjusting electrode dimensions |
US6985776B2 (en) | 2003-04-25 | 2006-01-10 | Medtronic, Inc. | Method and apparatus for coronary sinus cannulation |
US6980843B2 (en) | 2003-05-21 | 2005-12-27 | Stereotaxis, Inc. | Electrophysiology catheter |
US7163537B2 (en) | 2003-06-02 | 2007-01-16 | Biosense Webster, Inc. | Enhanced ablation and mapping catheter and method for treating atrial fibrillation |
US7044946B2 (en) | 2003-06-10 | 2006-05-16 | Cryocath Technologies Inc. | Surgical clamp having treatment elements |
US7540853B2 (en) * | 2003-06-30 | 2009-06-02 | Cardiac Pacemakers, Inc. | Method and apparatus for diverting blood flow during ablation procedures |
US6973339B2 (en) | 2003-07-29 | 2005-12-06 | Biosense, Inc | Lasso for pulmonary vein mapping and ablation |
US20060009755A1 (en) | 2003-09-04 | 2006-01-12 | Sra Jasbir S | Method and system for ablation of atrial fibrillation and other cardiac arrhythmias |
US7229437B2 (en) | 2003-09-22 | 2007-06-12 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Medical device having integral traces and formed electrodes |
US8147486B2 (en) | 2003-09-22 | 2012-04-03 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Medical device with flexible printed circuit |
US7435248B2 (en) | 2003-09-26 | 2008-10-14 | Boston Scientific Scimed, Inc. | Medical probes for creating and diagnosing circumferential lesions within or around the ostium of a vessel |
US7179256B2 (en) | 2003-10-24 | 2007-02-20 | Biosense Webster, Inc. | Catheter with ablation needle and mapping assembly |
US7207989B2 (en) | 2003-10-27 | 2007-04-24 | Biosense Webster, Inc. | Method for ablating with needle electrode |
JP4496223B2 (en) | 2003-11-06 | 2010-07-07 | エヌエムティー メディカル, インコーポレイティッド | Septal penetration device |
FR2861997A1 (en) | 2003-11-06 | 2005-05-13 | Fred Zacouto | Cardiac muscle stimulation device e.g. defibrillator, for use during tachycardia treatment, has impulse generator that sends stimulation pulse without delay at end of refractory period |
US7896873B2 (en) | 2003-12-01 | 2011-03-01 | Biotronik Crm Patent Ag | Electrode catheter for the electrotherapy of cardiac tissue |
EP2474281B1 (en) | 2003-12-24 | 2019-03-27 | The Regents of The University of California | Tissue ablation with irreversible electroporation |
US20060100610A1 (en) | 2004-03-05 | 2006-05-11 | Wallace Daniel T | Methods using a robotic catheter system |
EP1720480A1 (en) | 2004-03-05 | 2006-11-15 | Hansen Medical, Inc. | Robotic catheter system |
US8548583B2 (en) | 2004-03-10 | 2013-10-01 | Impulse Dynamics Nv | Protein activity modification |
US20050261672A1 (en) * | 2004-05-18 | 2005-11-24 | Mark Deem | Systems and methods for selective denervation of heart dysrhythmias |
US7250049B2 (en) | 2004-05-27 | 2007-07-31 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter with suspension system incorporating rigid and flexible components |
WO2005120375A2 (en) | 2004-06-02 | 2005-12-22 | Medtronic, Inc. | Loop ablation apparatus and method |
US7527625B2 (en) | 2004-08-04 | 2009-05-05 | Olympus Corporation | Transparent electrode for the radiofrequency ablation of tissue |
US7556627B2 (en) * | 2004-09-13 | 2009-07-07 | Ethicon Endo-Surgery, Inc. | Mucosal ablation device |
US7282049B2 (en) | 2004-10-08 | 2007-10-16 | Sherwood Services Ag | Electrosurgical system employing multiple electrodes and method thereof |
US20060089637A1 (en) | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
FR2877207B1 (en) * | 2004-10-29 | 2007-02-23 | Jacques Hamou | DEVICE FOR RESECTING ORGANIC TISSUE USED IN PARTICULAR IN UROLOGY OR HYSTEROSCOPY |
US8409191B2 (en) | 2004-11-04 | 2013-04-02 | Boston Scientific Scimed, Inc. | Preshaped ablation catheter for ablating pulmonary vein ostia within the heart |
US7468062B2 (en) | 2004-11-24 | 2008-12-23 | Ablation Frontiers, Inc. | Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use |
US7429261B2 (en) | 2004-11-24 | 2008-09-30 | Ablation Frontiers, Inc. | Atrial ablation catheter and method of use |
US7731715B2 (en) | 2004-12-10 | 2010-06-08 | Edwards Lifesciences Corporation | Ablative treatment of atrial fibrillation via the coronary sinus |
US7869865B2 (en) | 2005-01-07 | 2011-01-11 | Biosense Webster, Inc. | Current-based position sensing |
US20070225589A1 (en) | 2005-01-11 | 2007-09-27 | Viswanathan Raju R | Single catheter diagnosis, navigation and treatment of arrhythmias |
JP4926981B2 (en) | 2005-01-31 | 2012-05-09 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | System and method for guiding a catheter in electrophysiological intervention |
US9821158B2 (en) | 2005-02-17 | 2017-11-21 | Metacure Limited | Non-immediate effects of therapy |
US7588567B2 (en) | 2005-04-22 | 2009-09-15 | Abl Technologies, Llc | Method and system of stopping energy delivery of an ablation procedure with a computer based device for increasing safety of ablation procedures |
US7578816B2 (en) | 2005-04-22 | 2009-08-25 | Abl Technologies, Llc | Method and system of increasing safety of cardiac ablation procedures |
US7512447B2 (en) | 2005-04-25 | 2009-03-31 | Medtronic, Inc. | Medical electrical electrodes with conductive polymer |
US20060264752A1 (en) | 2005-04-27 | 2006-11-23 | The Regents Of The University Of California | Electroporation controlled with real time imaging |
US8571635B2 (en) | 2005-04-28 | 2013-10-29 | Boston Scientific Scimed, Inc. | Automated activation/deactivation of imaging device based on tracked medical device position |
US8932208B2 (en) | 2005-05-26 | 2015-01-13 | Maquet Cardiovascular Llc | Apparatus and methods for performing minimally-invasive surgical procedures |
US20060270900A1 (en) | 2005-05-26 | 2006-11-30 | Chin Albert K | Apparatus and methods for performing ablation |
US9861836B2 (en) | 2005-06-16 | 2018-01-09 | Biosense Webster, Inc. | Less invasive methods for ablation of fat pads |
CA2612679A1 (en) | 2005-06-20 | 2007-01-04 | Richardo D. Roman | Ablation catheter |
US20060293731A1 (en) | 2005-06-24 | 2006-12-28 | Boris Rubinsky | Methods and systems for treating tumors using electroporation |
US20060293730A1 (en) | 2005-06-24 | 2006-12-28 | Boris Rubinsky | Methods and systems for treating restenosis sites using electroporation |
US20070005053A1 (en) | 2005-06-30 | 2007-01-04 | Dando Jeremy D | Ablation catheter with contoured openings in insulated electrodes |
AU2006264300B2 (en) | 2005-07-06 | 2012-03-08 | Vascular Pathways Inc. | Intravenous catheter insertion device and method of use |
US20070021744A1 (en) | 2005-07-07 | 2007-01-25 | Creighton Francis M Iv | Apparatus and method for performing ablation with imaging feedback |
AU2006268238A1 (en) | 2005-07-11 | 2007-01-18 | Medtronic Ablation Frontiers Llc | Low power tissue ablation system |
ITBO20050495A1 (en) | 2005-07-22 | 2007-01-23 | Fiab Spa | EXOGUE PIPELINE |
US7681579B2 (en) | 2005-08-02 | 2010-03-23 | Biosense Webster, Inc. | Guided procedures for treating atrial fibrillation |
US8657814B2 (en) | 2005-08-22 | 2014-02-25 | Medtronic Ablation Frontiers Llc | User interface for tissue ablation system |
US7416552B2 (en) | 2005-08-22 | 2008-08-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Multipolar, multi-lumen, virtual-electrode catheter with at least one surface electrode and method for ablation |
US7623899B2 (en) | 2005-09-16 | 2009-11-24 | Biosense Webster, Inc. | Catheter with flexible pre-shaped tip section |
EP1956992B1 (en) | 2005-12-02 | 2013-03-06 | Koninklijke Philips Electronics N.V. | Automating the ablation procedure to minimize the need for manual intervention |
US8403925B2 (en) | 2006-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing lesions in tissue |
US10362959B2 (en) | 2005-12-06 | 2019-07-30 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the proximity of an electrode to tissue in a body |
US9492226B2 (en) | 2005-12-06 | 2016-11-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Graphical user interface for real-time RF lesion depth display |
US8449535B2 (en) | 2005-12-06 | 2013-05-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing coupling between an electrode and tissue |
US8406866B2 (en) | 2005-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing coupling between an electrode and tissue |
US8603084B2 (en) | 2005-12-06 | 2013-12-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the formation of a lesion in tissue |
WO2007076045A2 (en) | 2005-12-24 | 2007-07-05 | Crossman Arthur W | Circumferential ablation guide wire system and related method of using the same |
US20090240248A1 (en) | 2005-12-30 | 2009-09-24 | C.R. Bard , Inc | Methods and Apparatus for Ablation of Cardiac Tissue |
US20070167740A1 (en) | 2005-12-30 | 2007-07-19 | Grunewald Debby E | Magnetic stabilization of catheter location sensor |
US7857809B2 (en) | 2005-12-30 | 2010-12-28 | Biosense Webster, Inc. | Injection molded irrigated tip electrode and catheter having the same |
US20070156135A1 (en) | 2006-01-03 | 2007-07-05 | Boris Rubinsky | System and methods for treating atrial fibrillation using electroporation |
US7513896B2 (en) | 2006-01-24 | 2009-04-07 | Covidien Ag | Dual synchro-resonant electrosurgical apparatus with bi-directional magnetic coupling |
US7374567B2 (en) | 2006-01-25 | 2008-05-20 | Heuser Richard R | Catheter system for connecting adjacent blood vessels |
US7918850B2 (en) | 2006-02-17 | 2011-04-05 | Biosense Wabster, Inc. | Lesion assessment by pacing |
WO2007123770A2 (en) | 2006-03-31 | 2007-11-01 | Automated Medical Instruments, Inc. | System and method for advancing, orienting, and immobilizing on internal body tissue a catheter or therapeutic device |
US7615044B2 (en) | 2006-05-03 | 2009-11-10 | Greatbatch Ltd. | Deflectable sheath handle assembly and method therefor |
US20070270792A1 (en) | 2006-05-08 | 2007-11-22 | Willard Hennemann | Interferometric characterization of ablated tissue |
US20140276782A1 (en) | 2013-03-15 | 2014-09-18 | Larry D. Paskar | Catheter system |
US7729752B2 (en) | 2006-06-13 | 2010-06-01 | Rhythmia Medical, Inc. | Non-contact cardiac mapping, including resolution map |
US7515954B2 (en) | 2006-06-13 | 2009-04-07 | Rhythmia Medical, Inc. | Non-contact cardiac mapping, including moving catheter and multi-beat integration |
US7783352B1 (en) | 2006-06-23 | 2010-08-24 | Pacesetter, Inc. | Optimizing anti-tachycardia pacing for terminating atrial fibrillation |
US8920411B2 (en) | 2006-06-28 | 2014-12-30 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
WO2008134245A1 (en) | 2007-04-27 | 2008-11-06 | Cvdevices, Llc | Devices, systems, and methods for promotion of infarct healing and reinforcement of border zone |
WO2008010039A2 (en) | 2006-07-12 | 2008-01-24 | Les Hôpitaux Universitaires De Geneve | Medical device for tissue ablation |
US20080033426A1 (en) | 2006-07-27 | 2008-02-07 | Machell Charles H | Catheter system and method of use thereof |
US8273081B2 (en) | 2006-09-08 | 2012-09-25 | Stereotaxis, Inc. | Impedance-based cardiac therapy planning method with a remote surgical navigation system |
EP3527255B1 (en) | 2006-10-13 | 2020-08-05 | Cyberonics, Inc. | Obstructive sleep apnea treatment devices and systems |
AU2007231704B2 (en) | 2006-11-29 | 2011-02-24 | Cathrx Ltd | Heat treating a biological site in a patient's body |
US20080132884A1 (en) | 2006-12-01 | 2008-06-05 | Boris Rubinsky | Systems for treating tissue sites using electroporation |
US20080132885A1 (en) | 2006-12-01 | 2008-06-05 | Boris Rubinsky | Methods for treating tissue sites using electroporation |
EP2097762A1 (en) | 2006-12-22 | 2009-09-09 | Philips Intellectual Property & Standards GmbH | Transmission line for use in magnetic resonance system |
US8449537B2 (en) | 2006-12-29 | 2013-05-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter with thermally mediated catheter body for mitigating blood coagulation and creating larger lesion |
US8226648B2 (en) | 2007-12-31 | 2012-07-24 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Pressure-sensitive flexible polymer bipolar electrode |
US7883508B2 (en) | 2006-12-29 | 2011-02-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Contact-sensitive pressure-sensitive conductive composite electrode and method for ablation |
US8108069B2 (en) | 2007-01-10 | 2012-01-31 | Hansen Medical, Inc. | Robotic catheter system and methods |
US9924998B2 (en) | 2007-01-12 | 2018-03-27 | Atricure, Inc. | Ablation system, clamp and method of use |
US8588830B2 (en) * | 2007-02-02 | 2013-11-19 | Inovus Solar, Inc | Wireless autonomous solar-powered outdoor lighting and energy and information management network |
US20080200913A1 (en) | 2007-02-07 | 2008-08-21 | Viswanathan Raju R | Single Catheter Navigation for Diagnosis and Treatment of Arrhythmias |
US7655004B2 (en) | 2007-02-15 | 2010-02-02 | Ethicon Endo-Surgery, Inc. | Electroporation ablation apparatus, system, and method |
JP2008213793A (en) | 2007-03-08 | 2008-09-18 | Yamaha Motor Electronics Co Ltd | Immobilizer release signal authentication method |
WO2008118737A1 (en) | 2007-03-22 | 2008-10-02 | University Of Virginia Patent Foundation | Electrode catheter for ablation purposes and related method thereof |
US11058354B2 (en) | 2007-03-19 | 2021-07-13 | University Of Virginia Patent Foundation | Access needle with direct visualization and related methods |
US9468396B2 (en) | 2007-03-19 | 2016-10-18 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
DE202007004236U1 (en) * | 2007-03-22 | 2007-06-14 | Patent-Treuhand-Gesellschaft für elektrische Glühlampen mbH | Dielectric barrier discharge lamp with ignition aid |
JP5336465B2 (en) | 2007-03-26 | 2013-11-06 | ボストン サイエンティフィック リミテッド | High resolution electrophysiology catheter |
US8597288B2 (en) | 2008-10-01 | 2013-12-03 | St. Jude Medical, Artial Fibrillation Division, Inc. | Vacuum-stabilized ablation system |
EP2532320A3 (en) | 2007-04-19 | 2013-04-03 | Miramar Labs, Inc. | Apparatus for reducing sweat production |
EP2139416B1 (en) | 2007-05-09 | 2015-08-19 | Irvine Biomedical, Inc. | Basket catheter having multiple electrodes |
US8588885B2 (en) | 2007-05-09 | 2013-11-19 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Bendable catheter arms having varied flexibility |
US8641704B2 (en) | 2007-05-11 | 2014-02-04 | Medtronic Ablation Frontiers Llc | Ablation therapy system and method for treating continuous atrial fibrillation |
US8100900B2 (en) | 2007-05-11 | 2012-01-24 | Board Of Trustees Of The Leland Stanford Junior University | System for delivering therapy |
US8628522B2 (en) | 2007-05-21 | 2014-01-14 | Estech, Inc. (Endoscopic Technologies, Inc.) | Cardiac ablation systems and methods |
US10220187B2 (en) * | 2010-06-16 | 2019-03-05 | St. Jude Medical, Llc | Ablation catheter having flexible tip with multiple flexible electrode segments |
US7742810B2 (en) | 2007-05-23 | 2010-06-22 | Boston Scientific Neuromodulation Corporation | Short duration pre-pulsing to reduce stimulation-evoked side-effects |
US8160690B2 (en) | 2007-06-14 | 2012-04-17 | Hansen Medical, Inc. | System and method for determining electrode-tissue contact based on amplitude modulation of sensed signal |
US20090024084A1 (en) | 2007-07-16 | 2009-01-22 | Peritec Biosciences Ltd. | Multi-lumen catheter assembly and method of providing relative motion thereto |
US20090062788A1 (en) | 2007-08-31 | 2009-03-05 | Long Gary L | Electrical ablation surgical instruments |
US20090076500A1 (en) | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc | Multi-tine probe and treatment by activation of opposing tines |
US7614592B2 (en) * | 2007-10-04 | 2009-11-10 | Pearl K. Bean, legal representative | Device and method for securing a bow |
EP2205309A4 (en) | 2007-10-05 | 2011-05-11 | Coaptus Medical Corp | Systems and methods for transeptal cardiac procedures |
US8500697B2 (en) | 2007-10-19 | 2013-08-06 | Pressure Products Medical Supplies, Inc. | Transseptal guidewire |
US20100241185A1 (en) | 2007-11-09 | 2010-09-23 | University Of Virginia Patent Foundation | Steerable epicardial pacing catheter system placed via the subxiphoid process |
US8906011B2 (en) | 2007-11-16 | 2014-12-09 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
US9572583B2 (en) * | 2007-11-21 | 2017-02-21 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Methods and systems for occluding vessels during cardiac ablation |
US9452288B2 (en) | 2007-12-06 | 2016-09-27 | Boston Scientific Neuromodulation Corporation | Multimodal neurostimulation systems and methods |
US8353907B2 (en) | 2007-12-21 | 2013-01-15 | Atricure, Inc. | Ablation device with internally cooled electrodes |
US9877724B2 (en) | 2007-12-21 | 2018-01-30 | Michel Gagner | Methods and devices for endoscopically creating an anastomosis |
US8562600B2 (en) | 2007-12-27 | 2013-10-22 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Integration of control software with a medical device and system |
US9204927B2 (en) | 2009-05-13 | 2015-12-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for presenting information representative of lesion formation in tissue during an ablation procedure |
EP2231002A1 (en) | 2008-01-09 | 2010-09-29 | Mayo Foundation for Medical Education and Research | Mapping and ablation catheter system |
BRPI0906703A2 (en) | 2008-01-16 | 2019-09-24 | Catheter Robotics Inc | remotely controlled catheter insertion system |
US8235988B2 (en) | 2008-01-24 | 2012-08-07 | Coherex Medical, Inc. | Systems and methods for reduction of atrial fibrillation |
US8617145B2 (en) | 2008-01-25 | 2013-12-31 | Intrepid Medical, Inc. | Methods of treating a cardiac arrhythmia by thoracoscopic production of a Cox maze III lesion set |
US20090228003A1 (en) | 2008-03-04 | 2009-09-10 | Prorhythm, Inc. | Tissue ablation device using radiofrequency and high intensity focused ultrasound |
WO2009112269A2 (en) | 2008-03-12 | 2009-09-17 | Afreeze Gmbh | Ablation system |
US20100004623A1 (en) | 2008-03-27 | 2010-01-07 | Angiodynamics, Inc. | Method for Treatment of Complications Associated with Arteriovenous Grafts and Fistulas Using Electroporation |
US8538509B2 (en) | 2008-04-02 | 2013-09-17 | Rhythmia Medical, Inc. | Intracardiac tracking system |
US8992517B2 (en) | 2008-04-29 | 2015-03-31 | Virginia Tech Intellectual Properties Inc. | Irreversible electroporation to treat aberrant cell masses |
US9198733B2 (en) | 2008-04-29 | 2015-12-01 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for electroporation-based therapies |
US9867652B2 (en) | 2008-04-29 | 2018-01-16 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
US10702326B2 (en) | 2011-07-15 | 2020-07-07 | Virginia Tech Intellectual Properties, Inc. | Device and method for electroporation based treatment of stenosis of a tubular body part |
US8926606B2 (en) | 2009-04-09 | 2015-01-06 | Virginia Tech Intellectual Properties, Inc. | Integration of very short electric pulses for minimally to noninvasive electroporation |
US10448989B2 (en) | 2009-04-09 | 2019-10-22 | Virginia Tech Intellectual Properties, Inc. | High-frequency electroporation for cancer therapy |
WO2009137800A2 (en) | 2008-05-09 | 2009-11-12 | Angiodynamics, Inc. | Electroporation device and method |
US9474574B2 (en) | 2008-05-21 | 2016-10-25 | Atricure, Inc. | Stabilized ablation systems and methods |
US8206385B2 (en) | 2008-06-09 | 2012-06-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter assembly with front-loaded tip and multi-contact connector |
US20090306651A1 (en) | 2008-06-09 | 2009-12-10 | Clint Schneider | Catheter assembly with front-loaded tip |
WO2010007600A1 (en) | 2008-07-17 | 2010-01-21 | Maestroheart Sa | Medical device for tissue ablation |
US8585695B2 (en) | 2008-07-22 | 2013-11-19 | Hue-Teh Shih | Systems and methods for noncontact ablation |
US8221411B2 (en) | 2008-07-28 | 2012-07-17 | Medtronic, Inc. | Systems and methods for cardiac tissue electroporation ablation |
JP4545210B2 (en) | 2008-09-11 | 2010-09-15 | 日本ライフライン株式会社 | Defibrillation catheter |
US9119533B2 (en) | 2008-10-07 | 2015-09-01 | Mc10, Inc. | Systems, methods, and devices having stretchable integrated circuitry for sensing and delivering therapy |
US8137343B2 (en) | 2008-10-27 | 2012-03-20 | Rhythmia Medical, Inc. | Tracking system using field mapping |
US9220924B2 (en) | 2008-10-30 | 2015-12-29 | Vytronus, Inc. | System and method for energy delivery to tissue while monitoring position, lesion depth, and wall motion |
US9192789B2 (en) | 2008-10-30 | 2015-11-24 | Vytronus, Inc. | System and method for anatomical mapping of tissue and planning ablation paths therein |
US8414508B2 (en) | 2008-10-30 | 2013-04-09 | Vytronus, Inc. | System and method for delivery of energy to tissue while compensating for collateral tissue |
US9192769B2 (en) | 2008-10-31 | 2015-11-24 | Medtronic, Inc. | Shunt-current reduction techniques for an implantable therapy system |
US9795442B2 (en) | 2008-11-11 | 2017-10-24 | Shifamed Holdings, Llc | Ablation catheters |
US8475445B2 (en) | 2008-12-01 | 2013-07-02 | Daniel Soroff | Spectral analysis of intracardiac electrograms to predict identification of radiofrequency ablation sites |
US8475450B2 (en) | 2008-12-30 | 2013-07-02 | Biosense Webster, Inc. | Dual-purpose lasso catheter with irrigation |
US8361066B2 (en) | 2009-01-12 | 2013-01-29 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US20100191232A1 (en) | 2009-01-27 | 2010-07-29 | Boveda Marco Medical Llc | Catheters and methods for performing electrophysiological interventions |
US8231603B2 (en) | 2009-02-10 | 2012-07-31 | Angiodynamics, Inc. | Irreversible electroporation and tissue regeneration |
EP2395934B1 (en) | 2009-02-11 | 2019-04-17 | Boston Scientific Scimed, Inc. | Insulated ablation catheter devices |
US10166067B2 (en) | 2009-02-12 | 2019-01-01 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter and method for electically isolating cardiac tissue |
JP2012518470A (en) | 2009-02-20 | 2012-08-16 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Asymmetric bi-directional movable catheter sheath |
US8747297B2 (en) | 2009-03-02 | 2014-06-10 | Olympus Corporation | Endoscopic heart surgery method |
CN102421386A (en) | 2009-03-31 | 2012-04-18 | 安吉戴尼克公司 | System and method for estimating a treatment region for a medical treatment device and for interactively planning a treatment of a patient |
US8632534B2 (en) | 2009-04-03 | 2014-01-21 | Angiodynamics, Inc. | Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD) |
US8287532B2 (en) | 2009-04-13 | 2012-10-16 | Biosense Webster, Inc. | Epicardial mapping and ablation catheter |
WO2010120847A1 (en) | 2009-04-14 | 2010-10-21 | Old Dominion University Research Foundation | System and method for applying plasma sparks to tissue |
US9566107B2 (en) | 2009-04-22 | 2017-02-14 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and apparatus for radiofrequency ablation with increased depth and/or decreased volume of ablated tissue |
US8103338B2 (en) | 2009-05-08 | 2012-01-24 | Rhythmia Medical, Inc. | Impedance based anatomy generation |
US8571647B2 (en) | 2009-05-08 | 2013-10-29 | Rhythmia Medical, Inc. | Impedance based anatomy generation |
CA2703347C (en) | 2009-05-08 | 2016-10-04 | Endosense Sa | Method and apparatus for controlling lesion size in catheter-based ablation treatment |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
US8430875B2 (en) | 2009-05-19 | 2013-04-30 | Estech, Inc. (Endoscopic Technologies, Inc.) | Magnetic navigation systems and methods |
US8903488B2 (en) | 2009-05-28 | 2014-12-02 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
GB2472216A (en) * | 2009-07-28 | 2011-02-02 | Gyrus Medical Ltd | Bipolar electrosurgical instrument with four electrodes |
US20110028962A1 (en) | 2009-07-31 | 2011-02-03 | Randell Werneth | Adjustable pulmonary vein ablation catheter |
CN102639071B (en) | 2009-08-05 | 2016-01-20 | Scr有限公司 | For system, apparatus and method by ablation heart |
US9042969B2 (en) | 2009-08-12 | 2015-05-26 | Angel Medical Systems, Inc. | Heart rate correction system and methods for the detection of cardiac events |
US20110054487A1 (en) | 2009-09-02 | 2011-03-03 | Circulite, Inc. | Coaxial transseptal guide-wire and needle assembly |
US20150321021A1 (en) | 2009-09-03 | 2015-11-12 | The Johns Hopkins University | Method and device for treating cardiac arrhythmias |
US9642534B2 (en) | 2009-09-11 | 2017-05-09 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
US20110098694A1 (en) | 2009-10-28 | 2011-04-28 | Ethicon Endo-Surgery, Inc. | Methods and instruments for treating cardiac tissue through a natural orifice |
US9861438B2 (en) | 2009-12-11 | 2018-01-09 | Biosense Webster (Israel), Ltd. | Pre-formed curved ablation catheter |
US8608735B2 (en) | 2009-12-30 | 2013-12-17 | Biosense Webster (Israel) Ltd. | Catheter with arcuate end section |
US9005198B2 (en) | 2010-01-29 | 2015-04-14 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US20110190727A1 (en) * | 2010-02-02 | 2011-08-04 | Boston Scientific Scimed, Inc. | Intervascular catheter, system and method |
US8556891B2 (en) | 2010-03-03 | 2013-10-15 | Medtronic Ablation Frontiers Llc | Variable-output radiofrequency ablation power supply |
WO2011112248A2 (en) | 2010-03-08 | 2011-09-15 | Alpha Orthopaedics, Inc. | Methods and devices for real time monitoring of collagen and for altering collagen status |
JP5936141B2 (en) | 2010-04-08 | 2016-06-15 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | System for reconstructing cardiac information |
CN103096963B (en) | 2010-04-13 | 2016-02-17 | 森特里心脏股份有限公司 | The method entered for pericardium and device |
JP6085553B2 (en) | 2010-04-13 | 2017-02-22 | センターハート・インコーポレイテッドSentreHEART, Inc. | Devices and methods for accessing and delivering devices to the heart |
US9510894B2 (en) | 2010-04-28 | 2016-12-06 | Biosense Webster (Israel) Ltd. | Irrigated ablation catheter having irrigation ports with reduced hydraulic resistance |
US9943363B2 (en) | 2010-04-28 | 2018-04-17 | Biosense Webster, Inc. | Irrigated ablation catheter with improved fluid flow |
US9924997B2 (en) | 2010-05-05 | 2018-03-27 | Ablacor Medical Corporation | Anchored ablation catheter |
EP2566565B1 (en) | 2010-05-05 | 2017-10-25 | Automated Medical Instruments Inc. | Anchored cardiac ablation catheter |
US9655677B2 (en) | 2010-05-12 | 2017-05-23 | Shifamed Holdings, Llc | Ablation catheters including a balloon and electrodes |
DK2581058T3 (en) | 2010-06-08 | 2016-06-06 | Toray Industries | A catheter for measuring electrical potential |
ITRM20100314A1 (en) | 2010-06-09 | 2011-12-10 | Luca Viviana De | CATHETER WITH REVERSIBLE STABILITY, FOR STABILIZATION DURING THE ABLATION TRANSCATETERE BY MEANS OF RADIO FREQUENCY. |
US20120029512A1 (en) * | 2010-07-30 | 2012-02-02 | Willard Martin R | Balloon with surface electrodes and integral cooling for renal nerve ablation |
WO2012013243A1 (en) | 2010-07-30 | 2012-02-02 | Umc Utrecht Holding B.V. | Generator, combination of a generator and a catheter, and method for providing an electrical pulse |
JP2012050538A (en) | 2010-08-31 | 2012-03-15 | Terumo Corp | Ablation device |
US9289606B2 (en) | 2010-09-02 | 2016-03-22 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System for electroporation therapy |
US20120089089A1 (en) | 2010-10-12 | 2012-04-12 | Ethicon Endo-Surgery, Inc. | Methods of magnetically guiding and axially aligning distal ends of surgical devices |
WO2012051433A2 (en) | 2010-10-13 | 2012-04-19 | Angiodynamics, Inc. | System and method for electrically ablating tissue of a patient |
WO2012054762A2 (en) * | 2010-10-20 | 2012-04-26 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having expandable mesh structures for renal neuromodulation and associated systems and methods |
AU2011329669B2 (en) | 2010-11-19 | 2016-07-28 | Boston Scientific Scimed, Inc. | Renal nerve detection and ablation apparatus and method |
US9877781B2 (en) | 2010-11-19 | 2018-01-30 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Electrode catheter device with indifferent electrode for direct current tissue therapies |
US11246653B2 (en) * | 2010-12-07 | 2022-02-15 | Boaz Avitall | Catheter systems for cardiac arrhythmia ablation |
US20120232409A1 (en) * | 2010-12-15 | 2012-09-13 | Stahmann Jeffrey E | System and method for renal artery occlusion during renal denervation therapy |
US20120158021A1 (en) | 2010-12-19 | 2012-06-21 | Mitralign, Inc. | Steerable guide catheter having preformed curved shape |
US9308041B2 (en) | 2010-12-22 | 2016-04-12 | Biosense Webster (Israel) Ltd. | Lasso catheter with rotating ultrasound transducer |
DE102010064101B4 (en) | 2010-12-23 | 2017-02-23 | Siemens Healthcare Gmbh | Pair of endocardial and epicardial catheters and catheters |
US20120303019A1 (en) | 2010-12-25 | 2012-11-29 | Xue Zhao | Kind of cardiac ablation catheter with guide-wire |
CN105662421B (en) | 2010-12-27 | 2019-04-19 | 圣犹达医疗用品卢森堡控股有限公司 | Join prediction technique again based on the atrial wall electricity for measuring contact force in radiofrequency ablation procedures |
US9149327B2 (en) | 2010-12-27 | 2015-10-06 | St. Jude Medical Luxembourg Holding S.À.R.L. | Prediction of atrial wall electrical reconnection based on contact force measured during RF ablation |
US9572620B2 (en) | 2010-12-29 | 2017-02-21 | Kyungmoo Ryu | System and method for treating arrhythmias in the heart using information obtained from heart wall motion |
US9044245B2 (en) | 2011-01-05 | 2015-06-02 | Medtronic Ablation Frontiers Llc | Multipolarity epicardial radiofrequency ablation |
US9095262B2 (en) | 2011-01-05 | 2015-08-04 | Mehdi Razavi | Guided ablation devices, systems, and methods |
US9002442B2 (en) | 2011-01-13 | 2015-04-07 | Rhythmia Medical, Inc. | Beat alignment and selection for cardiac mapping |
CA2764494A1 (en) | 2011-01-21 | 2012-07-21 | Kardium Inc. | Enhanced medical device for use in bodily cavities, for example an atrium |
US9480525B2 (en) | 2011-01-21 | 2016-11-01 | Kardium, Inc. | High-density electrode-based medical device system |
US9314620B2 (en) | 2011-02-28 | 2016-04-19 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
KR102017532B1 (en) | 2011-03-08 | 2019-09-03 | 넥서스 컨트롤 시스템즈 엘엘씨 | Ablation catheter device with safety features |
US9937002B2 (en) | 2011-03-08 | 2018-04-10 | Nexus Control Systems, Llc | Ablation catheter system with safety features |
CA2832633A1 (en) | 2011-04-13 | 2012-10-18 | Vytronus, Inc. | Integrated ablation and mapping system |
EP2705464B1 (en) | 2011-05-02 | 2018-04-18 | Topera, Inc. | System and method for targeting heart rhythm disorders using shaped ablation |
KR101248959B1 (en) | 2011-05-12 | 2013-04-01 | 신경민 | Electrode device having flexible tube for high frequency thermotherapy |
US9072518B2 (en) | 2011-05-31 | 2015-07-07 | Atricure, Inc. | High-voltage pulse ablation systems and methods |
US20120310230A1 (en) | 2011-06-01 | 2012-12-06 | Angiodynamics, Inc. | Coaxial dual function probe and method of use |
US20120316557A1 (en) | 2011-06-08 | 2012-12-13 | Tyco Healthcare Group Lp | Septoplasty Instrument |
EP2720751B1 (en) | 2011-06-15 | 2015-04-15 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Apparatus for and method of terminating a high frequency arrhythmic electric state of a biological tissue |
JP6139518B2 (en) | 2011-07-05 | 2017-05-31 | カーディオインサイト テクノロジーズ インコーポレイテッド | Positioning for ECG mapping |
WO2013013099A1 (en) | 2011-07-19 | 2013-01-24 | Adagio Medical, Inc. | Methods and devices for the treatment of atrial fibrillation |
US9387031B2 (en) * | 2011-07-29 | 2016-07-12 | Medtronic Ablation Frontiers Llc | Mesh-overlayed ablation and mapping device |
US20130030430A1 (en) | 2011-07-29 | 2013-01-31 | Stewart Mark T | Intracardiac tools and methods for delivery of electroporation therapies |
EP2765940B1 (en) * | 2011-10-11 | 2015-08-26 | Boston Scientific Scimed, Inc. | Off-wall electrode device for nerve modulation |
WO2013096199A1 (en) | 2011-12-20 | 2013-06-27 | Cardiac Pacemakers, Inc. | Ectopic-triggered para-his stimulation |
US9037259B2 (en) * | 2011-12-23 | 2015-05-19 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US8825130B2 (en) | 2011-12-30 | 2014-09-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Electrode support structure assemblies |
US9687289B2 (en) | 2012-01-04 | 2017-06-27 | Biosense Webster (Israel) Ltd. | Contact assessment based on phase measurement |
JP6317927B2 (en) * | 2012-01-09 | 2018-04-25 | ムー・メディカル・デバイスズ・エルエルシーMoe Medical Devices Llc | Plasma assisted skin treatment |
EP2802282A1 (en) | 2012-01-10 | 2014-11-19 | Boston Scientific Scimed, Inc. | Electrophysiology system |
US9414881B2 (en) | 2012-02-08 | 2016-08-16 | Angiodynamics, Inc. | System and method for increasing a target zone for electrical ablation |
US8808273B2 (en) | 2012-02-10 | 2014-08-19 | Biosense Webster (Israel) Ltd. | Electrophysiology catheter with mechanical use limiter |
US9095350B2 (en) | 2012-05-01 | 2015-08-04 | Medtronic Ablation Frontiers Llc | Impedance detection of venous placement of multi-electrode catheters |
US9179972B2 (en) | 2012-05-04 | 2015-11-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for controlling delivery of ablation energy to tissue |
US9693832B2 (en) | 2012-05-21 | 2017-07-04 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
US9554847B2 (en) | 2012-07-02 | 2017-01-31 | Biosense Webster (Israel) Ltd. | Real time assessment of ablation from electrocardiogram signals |
US9101374B1 (en) | 2012-08-07 | 2015-08-11 | David Harris Hoch | Method for guiding an ablation catheter based on real time intracardiac electrical signals and apparatus for performing the method |
EP2882336B1 (en) | 2012-08-09 | 2019-06-26 | University of Iowa Research Foundation | Catheter systems for puncturing through a tissue structure |
US20140052216A1 (en) | 2012-08-15 | 2014-02-20 | Ethicon Endo-Surgery, Inc. | Methods for promoting wound healing |
US9277957B2 (en) | 2012-08-15 | 2016-03-08 | Ethicon Endo-Surgery, Inc. | Electrosurgical devices and methods |
US9801681B2 (en) | 2012-08-17 | 2017-10-31 | Medtronic Ablation Frontiers Llc | Catheters and methods for intracardiac electrical mapping |
US9168004B2 (en) | 2012-08-20 | 2015-10-27 | Biosense Webster (Israel) Ltd. | Machine learning in determining catheter electrode contact |
WO2014031800A1 (en) | 2012-08-22 | 2014-02-27 | Energize Medical Llc | Therapeutic energy systems |
US10004459B2 (en) | 2012-08-31 | 2018-06-26 | Acutus Medical, Inc. | Catheter system and methods of medical uses of same, including diagnostic and treatment uses for the heart |
JP2014054430A (en) * | 2012-09-13 | 2014-03-27 | Nippon Koden Corp | Catheter |
US11096741B2 (en) | 2012-10-10 | 2021-08-24 | Biosense Webster (Israel) Ltd. | Ablation power control based on contact force |
US9827036B2 (en) | 2012-11-13 | 2017-11-28 | Pulnovo Medical (Wuxi) Co., Ltd. | Multi-pole synchronous pulmonary artery radiofrequency ablation catheter |
US9757185B2 (en) | 2012-11-29 | 2017-09-12 | Gyrus Acmi, Inc. | Quadripolar forceps |
WO2014089373A1 (en) | 2012-12-05 | 2014-06-12 | University Of Rochester | Catheter with integrated transeptal puncture needle |
US9023036B2 (en) | 2012-12-07 | 2015-05-05 | Biosense Webster (Israel) Ltd. | Lasso catheter with tip electrode |
US9474850B2 (en) | 2012-12-11 | 2016-10-25 | Biosense Webster (Israel) Ltd. | Lasso catheter with guide wire |
US9078667B2 (en) | 2012-12-11 | 2015-07-14 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter having reduced force concentration at tissue contact site |
WO2014100579A1 (en) | 2012-12-21 | 2014-06-26 | David Anderson | Functional gain measurement technique and representation |
US10537286B2 (en) | 2013-01-08 | 2020-01-21 | Biosense Webster (Israel) Ltd. | Catheter with multiple spines of different lengths arranged in one or more distal assemblies |
EP2950734B1 (en) | 2013-01-31 | 2019-05-08 | Renal Dynamics Ltd. | Unipolar and/or bipolar ablation catheter |
US9031642B2 (en) | 2013-02-21 | 2015-05-12 | Medtronic, Inc. | Methods for simultaneous cardiac substrate mapping using spatial correlation maps between neighboring unipolar electrograms |
US9474486B2 (en) | 2013-03-08 | 2016-10-25 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Basket for a multi-electrode array catheter |
US9519021B2 (en) | 2013-03-11 | 2016-12-13 | Covidien Lp | Systems and methods for detecting abnormalities within a circuit of an electrosurgical generator |
US9486272B2 (en) | 2013-03-12 | 2016-11-08 | Biosense Webster (Israel) Ltd. | Force feedback device and method for catheters |
WO2014151273A1 (en) | 2013-03-15 | 2014-09-25 | Medtronic Ardian Luxembourg S.A.R.L. | Treatment device with electrode contact surface configured for enhancing uniformity of electrical energy distribution and associated devices and methods |
AU2014241205B2 (en) | 2013-03-27 | 2019-01-17 | Autonomix Medical, Inc. | Neurological traffic and receptor evaluation and modification: systems and methods |
EP2983603B1 (en) | 2013-04-08 | 2020-03-25 | Apama Medical, Inc. | Cardiac ablation catheters |
US10575743B2 (en) | 2013-04-11 | 2020-03-03 | Biosense Webster (Israel) Ltd. | High electrode density basket catheter |
EP3003192A1 (en) | 2013-06-05 | 2016-04-13 | Tel HaShomer Medical Research Infrastructure and Services Ltd. | Myocardial ablation by irreversible electroporation |
WO2015021113A1 (en) | 2013-08-06 | 2015-02-12 | Memorial Sloan Kettering Cancer Center | System, method and computer-accessible medium for in-vivo tissue ablation and/or damage |
EP3038704B1 (en) | 2013-08-29 | 2018-10-03 | Boston Scientific Neuromodulation Corporation | System for adjusting the compliance voltage in a neuromodulation device |
WO2015066322A1 (en) | 2013-11-01 | 2015-05-07 | Boston Scientific Scimed, Inc. | Cardiac mapping using latency interpolation |
US20150141978A1 (en) | 2013-11-20 | 2015-05-21 | Boston Scientific Scimed, Inc. | Ablation medical devices and methods for making and using ablation medical devices |
US20150173828A1 (en) | 2013-12-23 | 2015-06-25 | Boaz Avitall | Small loop ablation catheter |
WO2015099786A1 (en) | 2013-12-27 | 2015-07-02 | Empire Technology Development Llc | Devices and techniques for ablative treatment |
WO2015103530A1 (en) | 2014-01-06 | 2015-07-09 | Iowa Approach Inc. | Devices and methods for delivering therapeutic electrical impulses |
EP3091921B1 (en) | 2014-01-06 | 2019-06-19 | Farapulse, Inc. | Apparatus for renal denervation ablation |
WO2015123163A1 (en) | 2014-02-11 | 2015-08-20 | St. Jude Medical, Cardiology Division, Inc. | Ablation catheter and associated methods |
US10925474B2 (en) | 2014-02-17 | 2021-02-23 | Children's National Medical Center | Delivery tool and method for devices in the pericardial space |
JP6483717B2 (en) | 2014-02-25 | 2019-03-13 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | System and method for utilizing electrophysiological properties for classification of arrhythmia sources |
GEP20197025B (en) | 2014-03-20 | 2019-10-10 | S P A Atricath | Ablation catheter and ablation apparatus |
EP3119470B1 (en) | 2014-03-21 | 2021-09-15 | Mayo Foundation for Medical Education and Research | Multi-electrode epicardial pacing |
US9956035B2 (en) | 2014-03-27 | 2018-05-01 | Biosense Webster (Israel) Ltd. | Temperature measurement in catheter |
US20150289923A1 (en) | 2014-04-14 | 2015-10-15 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for electrical-energy based therapies based on cell characteristics |
US9717552B2 (en) | 2014-05-06 | 2017-08-01 | Cosman Intruments, Llc | Electrosurgical generator |
EP3495018B1 (en) | 2014-05-07 | 2023-09-06 | Farapulse, Inc. | Apparatus for selective tissue ablation |
WO2015175944A1 (en) | 2014-05-16 | 2015-11-19 | Gary Long | Methods and apparatus for multi-catheter tissue ablation |
US9848795B2 (en) | 2014-06-04 | 2017-12-26 | Boston Scientific Scimed Inc. | Electrode assembly |
EP3154463B1 (en) | 2014-06-12 | 2019-03-27 | Farapulse, Inc. | Apparatus for rapid and selective transurethral tissue ablation |
EP3154464A4 (en) | 2014-06-12 | 2018-01-24 | Iowa Approach Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
US12114911B2 (en) | 2014-08-28 | 2024-10-15 | Angiodynamics, Inc. | System and method for ablating a tissue site by electroporation with real-time pulse monitoring |
WO2016059027A1 (en) | 2014-10-13 | 2016-04-21 | Dr Philippe Debruyne Bvba | Limited ablation for the treatment of sick sinus syndrome and other inappropriate sinus bradycardias |
JP2017529169A (en) | 2014-10-13 | 2017-10-05 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Tissue diagnosis and treatment using mini-electrodes |
WO2016060983A1 (en) | 2014-10-14 | 2016-04-21 | Iowa Approach Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
US10231778B2 (en) | 2014-10-20 | 2019-03-19 | Biosense Webster (Israel) Ltd. | Methods for contemporaneous assessment of renal denervation |
EP4316361A3 (en) | 2014-10-24 | 2024-05-01 | Boston Scientific Scimed Inc. | Medical devices with a flexible electrode assembly coupled to an ablation tip |
JP6725178B2 (en) | 2014-11-19 | 2020-07-15 | エピックス セラピューティクス,インコーポレイテッド | Ablation apparatus, systems and methods using high resolution electrode assemblies |
EP3226795B1 (en) | 2014-12-03 | 2020-08-26 | Metavention, Inc. | Systems for modulating nerves or other tissue |
US10271893B2 (en) | 2014-12-15 | 2019-04-30 | Medtronic Ablation Frontiers Llc | Timed energy delivery |
WO2016100917A1 (en) | 2014-12-18 | 2016-06-23 | Boston Scientific Scimed Inc. | Real-time morphology analysis for lesion assessment |
US9782099B2 (en) | 2014-12-31 | 2017-10-10 | Biosense Webster (Israel) Ltd. | Basket catheter with improved spine flexibility |
JP2018515247A (en) | 2015-05-12 | 2018-06-14 | セント・ジュード・メディカル・エイトリアル・フィブリレーション・ディヴィジョン・インコーポレーテッド | Asymmetrically balanced waveform for AC heart irreversible electroporation |
CN107835705B (en) | 2015-05-12 | 2022-05-13 | 爱尔兰国立高威大学 | Devices for therapeutic nasal neuromodulation and associated methods and systems |
US20160361109A1 (en) | 2015-06-11 | 2016-12-15 | Massachusetts Institute Of Technology | Methods for inducing electroporation and tissue ablation |
US9949656B2 (en) | 2015-06-29 | 2018-04-24 | Biosense Webster (Israel) Ltd. | Catheter with stacked spine electrode assembly |
CN107921258B (en) | 2015-08-06 | 2021-09-07 | 美敦力公司 | Cardiac pulsed field ablation |
US9931487B2 (en) | 2015-08-06 | 2018-04-03 | Boston Scientific Scimed, Inc. | Bidirectional steering control apparatus for a catheter |
US20170071543A1 (en) | 2015-09-14 | 2017-03-16 | Biosense Webster (Israel) Ltd. | Convertible basket catheter |
WO2017062674A1 (en) | 2015-10-06 | 2017-04-13 | Halcyon Medical, Inc. | Aorticorenal ganglion detection |
US20170105793A1 (en) | 2015-10-15 | 2017-04-20 | Boston Scientific Scimed, Inc. | Energy delivery devices and related methods of use |
EP3383303B1 (en) | 2015-12-01 | 2024-04-10 | Symap Medical (Suzhou), Ltd. | System for mapping functional nerves innervating wall of arteries,3-d mapping and catheters for same |
US10130423B1 (en) | 2017-07-06 | 2018-11-20 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
CN108778173A (en) | 2016-01-05 | 2018-11-09 | 法拉普尔赛股份有限公司 | Systems, devices and methods for impulse electric field ablation energy to be delivered to endocardial tissue |
US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US20170189097A1 (en) | 2016-01-05 | 2017-07-06 | Iowa Approach Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
WO2017119934A1 (en) | 2016-01-05 | 2017-07-13 | Iowa Approach Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10548665B2 (en) | 2016-02-29 | 2020-02-04 | Pulse Biosciences, Inc. | High-voltage analog circuit pulser with feedback control |
US10874451B2 (en) | 2016-02-29 | 2020-12-29 | Pulse Biosciences, Inc. | High-voltage analog circuit pulser and pulse generator discharge circuit |
US10869719B2 (en) | 2016-05-02 | 2020-12-22 | Affera, Inc. | Pulsed radiofrequency ablation |
WO2017218734A1 (en) | 2016-06-16 | 2017-12-21 | Iowa Approach, Inc. | Systems, apparatuses, and methods for guide wire delivery |
CN114098949B (en) | 2016-06-27 | 2023-12-19 | 盖能适治疗股份有限公司 | Generator and catheter with electrode |
EP3537954B1 (en) | 2016-11-11 | 2021-07-21 | National University of Ireland, Galway | Devices, systems, and methods for specializing, monitoring, and/or evaluating therapeutic nasal neuromodulation |
US20180184982A1 (en) | 2017-01-05 | 2018-07-05 | Biosense Webster (Israel) Ltd. | Hybrid balloon basket catheter |
US10912609B2 (en) | 2017-01-06 | 2021-02-09 | St. Jude Medical, Cardiology Division, Inc. | Pulmonary vein isolation balloon catheter |
EP3612103B1 (en) | 2017-04-20 | 2022-02-09 | Medtronic, Inc. | Stabilization of a transseptal delivery device |
US9987081B1 (en) | 2017-04-27 | 2018-06-05 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
US10617867B2 (en) | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
WO2018226761A1 (en) | 2017-06-06 | 2018-12-13 | Cardiac Pacemakers, Inc. | Ablation delivery using a catheter having a semi-permeable inflatable balloon structure |
US20180360534A1 (en) | 2017-06-19 | 2018-12-20 | St. Jude Medical, Cardiology Division, Inc. | Apparatuses and methods for high-density sensing and ablation during a medical procedure |
US11612334B2 (en) | 2017-12-19 | 2023-03-28 | St. Jude Medical, Cardiology Division, Inc. | Methods of assessing contact between an electrode and tissue using complex impedance measurements |
CN111698959B (en) | 2017-12-26 | 2023-07-11 | 盖能适治疗股份有限公司 | Methods, devices and systems for treatment of disease states and conditions |
US20190336198A1 (en) | 2018-05-03 | 2019-11-07 | Farapulse, Inc. | Systems, devices, and methods for ablation using surgical clamps |
WO2019217433A1 (en) | 2018-05-07 | 2019-11-14 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US20220211426A1 (en) | 2019-05-17 | 2022-07-07 | Mayo Foundation For Medical Education And Research | Catheters that deliver pulsed electrical field for targeted cellular ablation |
US20210015550A1 (en) | 2019-07-17 | 2021-01-21 | Biosense Webster (Israel) Ltd. | Catheter for endovascular sympathetic denervation of spasmed intracranial arteries |
-
2015
- 2015-01-06 EP EP15733297.4A patent/EP3091921B1/en active Active
- 2015-01-06 WO PCT/US2015/010223 patent/WO2015103574A1/en active Application Filing
-
2016
- 2016-07-05 US US15/201,997 patent/US10517672B2/en active Active
-
2019
- 2019-12-18 US US16/719,708 patent/US11589919B2/en active Active
-
2023
- 2023-02-16 US US18/170,348 patent/US20230190368A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2015103574A1 (en) | 2015-07-09 |
US10517672B2 (en) | 2019-12-31 |
US20160310211A1 (en) | 2016-10-27 |
EP3091921A4 (en) | 2017-09-13 |
EP3091921B1 (en) | 2019-06-19 |
EP3091921A1 (en) | 2016-11-16 |
US11589919B2 (en) | 2023-02-28 |
US20200297411A1 (en) | 2020-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230190368A1 (en) | Apparatus and methods for renal denervation ablation | |
US20240315769A1 (en) | Methods and apparatus for selective tissue ablation | |
US20220257938A1 (en) | Expandable elements for delivery of electric fields | |
CN111065327B (en) | Systems, devices, and methods for ventricular focal ablation | |
EP3884895B1 (en) | Electroporation systems and catheters for electroporation systems | |
JP6854015B2 (en) | Devices and related methods and systems for therapeutic nasal nerve regulation | |
JP6611722B2 (en) | Devices and methods for delivering therapeutic electrical impulses | |
US20220133403A1 (en) | Systems and methods for ablation using non-adjacent bipoles | |
WO2021173215A1 (en) | Electrode assembly including expandable isolation member | |
JP7428816B2 (en) | Electrode assembly including expandable isolation member | |
US12121290B2 (en) | Electrode assembly including expandable isolation member | |
US20240099769A1 (en) | Methods and Systems for Thermal Enhancement of Electroporation | |
CN112716599A (en) | Electrode assembly including expandable spacer member |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FARAPULSE, INC.;REEL/FRAME:067118/0441 Effective date: 20210806 Owner name: IOWA APPROACH, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LONG, GARY;GLL, LLC;REEL/FRAME:067117/0773 Effective date: 20150410 Owner name: FARAPULSE, INC., CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:IOWA APPROACH, INC.;REEL/FRAME:067125/0398 Effective date: 20180531 |